CNL Healthcare Properties (CHTH) 10-Q 8 Nov 19 2019 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2019	Oct. 31, 2019
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q3
Entity Registrant Name	CNL Healthcare Properties, Inc.
Trading Symbol	N/A
Entity Central Index Key	0001496454
Entity Current Reporting Status	Yes
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity File Number	000-54685
Entity Tax Identification Number	27-2876363
Entity Address, Address Line One	CNL Center at City Commons
Entity Address, Address Line Two	450 South Orange Avenue
Entity Address, City or Town	Orlando
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	32801
City Area Code	407
Local Phone Number	650-1000
Entity Common Stock, Shares Outstanding		173,963,445
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	MD
Document Quarterly Report	true
Document Transition Report	false
Title of 12(b) Security	None

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Thousands		Sep. 30, 2019	Dec. 31, 2018
ASSETS
Real estate investment properties, net (including VIEs $69,411 and $146,341, respectively)		$ 1,422,299	$ 1,455,149
Assets held for sale, net (including VIEs $0 and $39,601, respectively)		146,719	1,147,645
Cash (including VIEs $549 and $342, respectively)		37,974	57,109
Other assets (including VIEs $598 and $678, respectively)		27,772	23,488
Deferred rent and lease incentives (including VIEs $0 and $7,160, respectively)		15,452	14,763
Restricted cash (including VIEs $111 and $208, respectively)		5,309	6,119
Intangibles, net		1,319	1,614
Total assets		1,656,844	2,705,887
Liabilities:
Mortgages and other notes payable, net (including VIEs $41,816 and $102,578, respectively)		434,923	530,644
Credit facilities		282,832	425,613
Accounts payable and accrued liabilities (including VIEs $1,139 and $784, respectively)		24,669	21,882
Other liabilities (including VIEs $236 and $1,321, respectively)		8,997	8,548
Due to related parties	[1]	2,171	3,255
Liabilities associated with assets held for sale (including VIEs $0 and $30,695, respectively)		1,076	774,019
Total liabilities		754,668	1,763,961
Commitments and contingencies (Note 13)
Redeemable noncontrolling interest		595	579
Stockholders' equity:
Preferred stock, $0.01 par value per share, 200,000 shares authorized; none issued or outstanding
Excess shares, $0.01 par value per share, 300,000 shares authorized; none issued or outstanding
Common stock, $0.01 par value per share, 1,120,000 shares authorized,186,626 and 186,626 shares issued, and 173,963 and 173,963 shares outstanding, respectively		1,740	1,740
Capital in excess of par value		1,516,949	1,516,543
Accumulated income (loss)		112,961	(233,847)
Accumulated distributions		(731,332)	(345,347)
Accumulated other comprehensive income (loss)		(60)	1,177
Total stockholders' equity		900,258	940,266
Noncontrolling interest		1,323	1,081
Total equity		902,176	941,926
Total liabilities and equity		$ 1,656,844	$ 2,705,887
[1]	Amounts are recorded as due to related parties in the accompanying condensed consolidated balance sheets.

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Real estate investment properties, net	$ 1,422,299	$ 1,455,149
Assets held for sale, net	146,719	1,147,645
Restricted cash	5,309	6,119
Cash	37,974	57,109
Deferred rent and lease incentives	15,452	14,763
Other assets	27,772	23,488
Mortgages and other notes payable, net	434,923	530,644
Liabilities associated with assets held for sale	1,076	774,019
Other liabilities	8,997	8,548
Accounts payable and accrued liabilities	$ 24,669	$ 21,882
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	200,000,000	200,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Excess shares, par value	$ 0.01	$ 0.01
Excess shares, shares authorized	300,000,000	300,000,000
Excess shares, shares issued	0	0
Excess shares, shares outstanding	0	0
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	1,120,000,000	1,120,000,000
Common stock, shares issued	186,626,000	186,626,000
Common stock, shares outstanding	173,963,000	173,963,000
VIEs
Real estate investment properties, net	$ 69,411	$ 146,341
Assets held for sale, net	0	39,601	[1]
Restricted cash	111	208
Cash	549	342
Deferred rent and lease incentives	0	7,160
Other assets	598	678
Mortgages and other notes payable, net	41,816	102,578
Liabilities associated with assets held for sale	0	30,695	[1]
Other liabilities	236	1,321
Accounts payable and accrued liabilities	$ 1,139	$ 784
[1]	Refer to Note 5. “Assets and Associated Liabilities Held For Sale and Discontinued Operations” for additional information.

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Revenues:
Rental income and related revenues	$ 7,913	$ 8,678	$ 25,095	$ 26,225
Resident fees and services	$ 72,289	$ 69,793	$ 215,452	$ 205,754
Type of revenue [extensible list]	us-gaap:HealthCareResidentServiceMember	us-gaap:HealthCareResidentServiceMember	us-gaap:HealthCareResidentServiceMember	us-gaap:HealthCareResidentServiceMember
Total revenues	$ 80,202	$ 78,471	$ 240,547	$ 231,979
Operating expenses:
Property operating expenses	47,496	45,466	140,079	134,024
General and administrative expenses	2,131	2,672	10,315	9,033
Financing coordination fees			1,878
Depreciation and amortization	12,337	12,862	37,018	41,528
Total operating expenses	69,148	68,373	212,534	209,157
Gain on sale of real estate			228	1,049
Operating income	11,054	10,098	28,241	23,871
Other income (expense):
Interest and other income	193	106	1,239	202
Interest expense and loan cost amortization	(9,174)	(10,247)	(31,822)	(31,097)
Equity in earnings of unconsolidated entity	220	267	414	438
Total other expense	(8,761)	(9,874)	(30,169)	(30,457)
Income (loss) before income taxes	2,293	224	(1,928)	(6,586)
Income tax expense	(702)	(859)	(1,890)	(2,404)
Income (loss) from continuing operations	1,591	(635)	(3,818)	(8,990)
Income (loss) from discontinued operations	3,877	(2,634)	347,721	(9,511)
Net income (loss)	5,468	(3,269)	343,903	(18,501)
Less: Amounts attributable to noncontrolling interest
Net income (loss) from continuing operations	14	(22)	12	(64)
Net income (loss) from discontinued operations		1	265	(7)
Net income (loss) attributable to common stockholders	$ 5,454	$ (3,248)	$ 343,626	$ (18,430)
Net income (loss) per share of common stock (basic and diluted)
Continuing operations	$ 0.01	$ 0	$ (0.02)	$ (0.06)
Discontinued operations	$ 0.02	$ (0.02)	$ 2	$ (0.05)
Weighted average number of shares of common stock outstanding (basic and diluted)	173,963	173,974	173,963	174,340
Asset Management Fees
Operating expenses:
Asset /Property management fees	$ 4,590	$ 4,558	$ 13,772	$ 13,693
Property Management Fees
Operating expenses:
Asset /Property management fees	$ 2,594	$ 2,815	$ 9,472	$ 10,879

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Statement Of Income And Comprehensive Income [Abstract]
Net income (loss)	$ 5,468	$ (3,269)	$ 343,903	$ (18,501)
Other comprehensive income (loss):
Unrealized gain (loss) on derivative financial instruments, net	32	(245)	(1,004)	3,278
Reclassification of interest rate swaps upon derecognition		14	(509)	267
Reclassification of interest rate caps upon derecognition			265
Unrealized gain (loss) on derivative financial instruments of equity method investments	(1)		11
Total other comprehensive income (loss)	31	(231)	(1,237)	3,545
Comprehensive income (loss)	5,499	(3,500)	342,666	(14,956)
Less: Comprehensive income (loss) attributable to noncontrolling interest	14	(21)	277	(71)
Comprehensive income (loss) attributable to common stockholders	$ 5,485	$ (3,479)	$ 342,389	$ (14,885)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (UNAUDITED) - USD ($)	Total	Redeemable Noncontrolling Interest	Common Stock	Capital in Excess of Par Value	Accumulated Income (Loss)	Accumulated Distributions	Accumulated Other Comprehensive Income (Loss)	Total Stockholders' Equity	Non- controlling Interest
Balance at Dec. 31, 2017	$ 1,052,660,000	$ 425,000	$ 1,747,000	$ 1,523,372,000	$ (208,775,000)	$ (264,283,000)	$ (985,000)	$ 1,051,076,000	$ 1,159,000
Beginning Balance (in shares) at Dec. 31, 2017			174,634,000
Subscriptions received for common stock through reinvestment plan	22,013,000		$ 21,000	21,992,000				22,013,000
Subscriptions received for common stock through public offering and reinvestment plan (in shares)			2,133,000
Redemptions of common stock	(28,340,000)		$ (28,000)	(28,312,000)				(28,340,000)
Redemption of common stock, shares			(2,793,000)
Net income (loss)	(18,501,000)	(17,000)			(18,430,000)			(18,430,000)	(54,000)
Other comprehensive income (loss)	3,545,000						3,545,000	3,545,000
Distributions to holders of promoted interest	(2,702,000)			(2,702,000)				(2,702,000)
Distribution to holder of noncontrolling interest	(14,000)								(14,000)
Cash distributions declared	(60,818,000)					(60,818,000)		(60,818,000)
Contribution from noncontrolling interests	18,000	18,000
Balance at Sep. 30, 2018	967,861,000	426,000	$ 1,740,000	1,514,350,000	(227,205,000)	(325,101,000)	2,560,000	966,344,000	1,091,000
Ending Balance (in shares) at Sep. 30, 2018			173,974,000
Balance at Jun. 30, 2018	994,322,000	421,000	$ 1,740,000	1,517,072,000	(223,957,000)	(304,854,000)	2,791,000	992,792,000	1,109,000
Beginning Balance (in shares) at Jun. 30, 2018			173,976,000
Redemptions of common stock	(20,000)			(20,000)				(20,000)
Redemption of common stock, shares			(2,000)
Net income (loss)	(3,269,000)	(9,000)			(3,248,000)			(3,248,000)	(12,000)
Other comprehensive income (loss)	(231,000)						(231,000)	(231,000)
Distributions to holders of promoted interest	(2,702,000)			(2,702,000)				(2,702,000)
Distribution to holder of noncontrolling interest	(6,000)								(6,000)
Cash distributions declared	(20,247,000)					(20,247,000)		(20,247,000)
Contribution from noncontrolling interests	14,000	14,000
Balance at Sep. 30, 2018	967,861,000	426,000	$ 1,740,000	1,514,350,000	(227,205,000)	(325,101,000)	2,560,000	966,344,000	1,091,000
Ending Balance (in shares) at Sep. 30, 2018			173,974,000
Balance at Dec. 31, 2018	$ 941,926,000	579,000	$ 1,740,000	1,516,543,000	(233,847,000)	(345,347,000)	1,177,000	940,266,000	1,081,000
Beginning Balance (in shares) at Dec. 31, 2018	173,963,000		173,963,000
Adoption of Lease ASU (refer to Note 2) | Adoption of ASC 842	$ 3,182,000				3,182,000			3,182,000
Subscriptions received for common stock through reinvestment plan	0
Net income (loss)	343,903,000	16,000			343,626,000			343,626,000	261,000
Other comprehensive income (loss)	(1,237,000)						(1,237,000)	(1,237,000)
Distributions to holders of promoted interest	406,000			406,000				406,000
Distribution to holder of noncontrolling interest	(610,000)								(610,000)
Cash distributions declared	(385,985,000)					(385,985,000)		(385,985,000)
Contribution from noncontrolling interests	591,000								591,000
Balance at Sep. 30, 2019	$ 902,176,000	595,000	$ 1,740,000	1,516,949,000	112,961,000	(731,332,000)	(60,000)	900,258,000	1,323,000
Ending Balance (in shares) at Sep. 30, 2019	173,963,000		173,963,000
Balance at Jun. 30, 2019	$ 905,664,000	587,000	$ 1,740,000	1,516,949,000	107,507,000	(722,425,000)	(91,000)	903,680,000	1,397,000
Beginning Balance (in shares) at Jun. 30, 2019			173,963,000
Subscriptions received for common stock through reinvestment plan	0
Net income (loss)	5,468,000	8,000			5,454,000			5,454,000	6,000
Other comprehensive income (loss)	31,000						31,000	31,000
Distribution to holder of noncontrolling interest	(80,000)								(80,000)
Cash distributions declared	(8,907,000)					(8,907,000)		(8,907,000)
Balance at Sep. 30, 2019	$ 902,176,000	$ 595,000	$ 1,740,000	$ 1,516,949,000	$ 112,961,000	$ (731,332,000)	$ (60,000)	$ 900,258,000	$ 1,323,000
Ending Balance (in shares) at Sep. 30, 2019	173,963,000		173,963,000

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (UNAUDITED) (Parenthetical) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Statement Of Stockholders Equity [Abstract]
Cash distributions, declared per share	$ 0.0512	$ 0.11639	$ 2.21879	$ 0.34917

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Operating activities:
Net cash flows provided by operating activities – continuing operations	$ 35,979	$ 30,381
Net cash flows provided by operating activities – discontinued operations	17,916	22,137
Net cash flows provided by operating activities	53,895	52,518
Investing activities:
Development of properties		(1,040)
Capital expenditures	(4,209)	(5,980)
Proceeds from sale of real estate	246	5,761
Other investing activities	993	161
Net cash used in investing activities – continuing operations	(2,970)	(1,098)
Development of properties	(80)	(1,173)
Capital expenditures	(1,713)	(932)
Proceeds from sale of real estate	1,312,479
Other investing activities	(721)	(1,667)
Net cash provided by (used in) investing activities – discontinued operations	1,309,965	(3,772)
Net cash provided by (used in) investing activities	1,306,995	(4,870)
Financing activities:
Distributions to stockholders, net of distribution reinvestments	(385,985)	(38,805)
Redemptions of common stock		(40,050)
Draws under credit facilities	55,000	72,000
Repayments on credit facilities	(444,125)	(25,000)
Proceeds from mortgages and other notes payable	178	40,459
Principal payments on mortgages and other notes payable	(600,747)	(63,712)
Payment of loan costs	(6,028)	(965)
Other financing activities	(1,170)	(1,465)
Net cash flows used in financing activities	(1,382,877)	(57,538)
Net decrease in cash and restricted cash	(21,987)	(9,890)
Cash and restricted cash at beginning of period, including held for sale	65,501	74,691
Cash and restricted cash at end of period, including held for sale	$ 43,514	$ 64,801

Organization

Organization	9 Months Ended
	Sep. 30, 2019
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Organization	1. Organization CNL Healthcare Properties, Inc. (“Company”) is a Maryland corporation that incorporated on June 8, 2010 and elected to be taxed as a real estate investment trust (“REIT”) for United States (“U.S.”) federal income tax purposes beginning with the year ended December 31, 2012. The Company’s intention is to be organized and operate in a manner that allows it to remain qualified as a REIT for U.S. federal income tax purposes. The Company conducts substantially all of its operations either directly or indirectly through: (1) an operating partnership, CHP Partners, LP (“Operating Partnership”), in which the Company is the sole limited partner and its wholly-owned subsidiary, CHP GP, LLC, is the sole general partner; (2) a wholly-owned taxable REIT subsidiary (“TRS”), CHP TRS Holding, Inc.; (3) property owner and lender subsidiaries, which are single purpose entities; and (4) investments in joint ventures. The Company is externally managed and advised by CNL Healthcare Corp. (“Advisor”), which is an affiliate of CNL Financial Group, LLC (“Sponsor”). The Advisor is responsible for managing the Company’s day-to-day operations, serving as a consultant in connection with policy decisions to be made by the board of directors, and for identifying, recommending and executing on strategic alternatives and dispositions on the Company’s behalf pursuant to an advisory agreement among the Company, the Operating Partnership and the Advisor. Substantially all of the Company’s acquisition services were, and substantially all of the Company’s operating, administrative and certain property management services are, provided by affiliates of the Advisor. In addition, certain property management services are provided by third-party property managers. On September 30, 2015, the Company completed its public offerings (“Offerings”) and received aggregate subscription proceeds of approximately $1.7 billion. In October 2015, the Company deregistered the unsold shares of its common stock under its previous registration statement on Form S-11, except for 20 million shares that it registered on Form S-3 under the Securities Exchange Act of 1933 with the Securities and Exchange Commission (“SEC”) for the sale of additional shares of common stock through its distribution reinvestment plan (“Reinvestment Plan”). Effective July 11, 2018, the Company suspended both its Reinvestment Plan and its stock redemption plan (“Redemption Plan”). In 2017, the Company began evaluating strategic alternatives to provide liquidity to its stockholders. In April 2018, the Company’s board of directors formed a special committee consisting solely of its independent directors (“Special Committee”) to consider possible strategic alternatives, including, but not limited to (i) the listing of the Company’s or one of its subsidiaries’ common stock on a national securities exchange, (ii) an orderly disposition of the Company’s assets or one or more of the Company’s asset classes and the distribution of the net sale proceeds thereof to the stockholders of the Company, and (iii) a potential business combination or other transaction with a third-party or parties that provides the stockholders of the Company with cash and/or securities of a publicly traded company (collectively, among other options, “Possible Strategic Alternatives”). The Special Committee engaged HFF Securities L.P. and KeyBanc Capital Markets Inc. to act as financial advisors in connection with exploring Possible Strategic Alternatives. As part of executing on Possible Strategic Alternatives, the Company committed to a plan to sell a total of 70 properties, classified these 70 properties as held for sale and, as of September 30, 2019, the Company had sold 59 of the aforementioned 70 properties. In October 2019, the Company completed the sale of an acute care facility in Beaumont, Texas (“Beaumont Sale”); refer to Note 14. “Subsequent Events” for additional information. In December 2018, the Company entered into an agreement of purchase and sale (“MOB Sale Agreement”) with a subsidiary of Welltower Inc. (NYSE: WELL) for the sale of 55 medical office buildings and related properties (“MOB Sale”) for a gross sales price of $1.25 billion, subject to certain pro-rations and other adjustments as described in the MOB Sale Agreement. In May 2019, the Company completed the MOB Sale and used the net cash proceeds to: (1) repay indebtedness secured by or allocated to the 55 properties comprising the MOB Sale; (2) rebalance other corporate borrowings and (3) make a special cash distribution to the Company’s stockholders. 1. Organization (continued) In March 2019, the Company entered into an agreement of purchase and sale (“IRF Sale Agreement”) for the sale of four post-acute care properties (“IRF Sale”) with subsidiaries of Global Medical REIT Inc. (NYSE: GMRE) for a gross sales price of $94 million, subject to certain pro-rations and other adjustments as described in the IRF Sale Agreement. In April 2019, the Company completed the IRF Sale and used the net cash proceeds to repay indebtedness secured by or cross-collateralized with the four properties comprising the IRF Sale. In June 2019, the Company terminated its engagement of HFF Securities L.P., one of the financial advisors to the Special Committee in connection with exploring Possible Strategic Alternatives, subject to a 12-month tail of certain fees and obligations under the terminated engagement letter. In July 2019, the Company entered into a purchase and sale agreement (“Beaumont Sale Agreement”) with Global Medical REIT, L.P., (NYSE: GMRE) related to the Beaumont Sale for a gross sales price of $33.6 million, subject to certain pro-rations and other adjustments as described in the Beaumont Sale Agreement. In October 2019, the Company completed the Beaumont Sale; refer to Note 14. “Subsequent Events” for additional information. In October 2019, the Company entered into an asset purchase agreement (“Grand Junction Sale Agreement”) with an affiliate of the tenant at Welbrook Senior Living Grand Junction related to the sale of a post-acute care property located in Colorado (“Grand Junction Sale”); refer to Note 14. “Subsequent Events” for additional information. As of September 30, 2019, including the 11 remaining properties classified as held for sale, the Company’s healthcare investment portfolio is geographically diversified with properties in 30 states and consisted of interests in 83 properties, including 72 seniors housing properties, eight post-acute care facilities and three acute care hospitals. The Company has primarily leased its seniors housing properties to wholly-owned TRS entities and engaged independent third-party managers under management agreements to operate the properties under the REIT Investment Diversification and Empowerment Act of 2007 (“RIDEA”) structures; however, the Company has also leased its properties to third-party tenants under triple-net or similar lease structures, where the tenant bears all or substantially all of the costs (including cost increases, for real estate taxes, utilities, insurance and ordinary repairs). In addition, although most of the Company’s investments have been wholly owned, it has invested through partnerships with other entities where it is believed to be appropriate and beneficial.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2019
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Basis of Presentation and Consolidation — The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and note disclosures required by generally accepted accounting principles in the U.S. (“GAAP”). The unaudited condensed consolidated financial statements reflect all normal recurring adjustments, which, in the opinion of management, are necessary for the fair statement of the Company’s results for the interim period presented. Operating results for the quarter and nine months ended September 30, 2019 may not be indicative of the results that may be expected for the year ending December 31, 2019. Amounts as of December 31, 2018 included in the unaudited condensed consolidated financial statements have been derived from audited consolidated financial statements as of that date but do not include all disclosures required by GAAP. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 (“Annual Report”). The accompanying unaudited condensed consolidated financial statements include the Company’s accounts, the accounts of wholly owned subsidiaries or subsidiaries for which the Company has a controlling interest, the accounts of variable interest entities (“VIEs”) in which the Company is the primary beneficiary, and the accounts of other subsidiaries over which the Company has a controlling financial interest. All material intercompany accounts and transactions have been eliminated in consolidation. 2. Summary of Significant Accounting Policies (continued) In accordance with the guidance for the consolidation of a VIE, the Company is required to identify entities for which control is achieved through means other than voting rights and to determine the primary beneficiary of its VIEs. The Company qualitatively assesses whether it is the primary beneficiary of a VIE and considers various factors including, but not limited to, the design of the entity, its organizational structure including decision-making ability and financial agreements, its ability and the rights of others to participate in policy making decisions, as well as its ability to replace the VIE manager and/or liquidate the entity. Reclassifications – Certain amounts in the prior year’s condensed consolidated statement of cash flows have been reclassified to conform to the current year’s presentation, primarily related to classification of certain properties as discontinued operations, with no effect on the other previously reported consolidated financial statements. Use of Estimates — The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements, the reported amounts of revenues and expenses during the reporting periods and the disclosure of contingent liabilities. For example, significant assumptions are made in the analysis of real estate impairments, the valuation of contingent assets and liabilities, and the valuation of restricted common stock (“Restricted Stock”) shares issued to the Advisor. Accordingly, actual results could differ from those estimates. Adopted Accounting Pronouncements — In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016-02, “Leases (Topic 842): Accounting for Leases,” which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e., lessees and lessors). The ASU requires lessees to recognize assets and liabilities on the balance sheet for the rights and obligations created by all leases with terms of more than 12 months. The ASU further modifies lessors’ classification criteria for leases and the accounting for sales-type and direct financing leases. The ASU also requires qualitative and quantitative disclosures designed to give financial statement users additional information on the amount, timing, and uncertainty of cash flows arising from leases. In July 2018, the FASB issued ASU 2018-11, “Leases (Topic 842): Targeted Improvements,” which includes a practical expedient for lessors that allows them to elect to not separate lease and non-lease components in a contract for the purpose of revenue recognition and disclosure if certain criteria are met. The Company elected this practical expedient and applied the guidance to all of the leases that qualified under the established criteria. In December 2018, the FASB issued ASU 2018-20, “Leases (Topic 842): Narrow-Scope Improvements for Lessors,” which addressed challenges encountered in determining certain lessor costs paid by the lessee directly to third parties by allowing lessors to exclude these costs from its variable lease payments. This amendment did not have a material impact on the Company’s financial statements and related disclosures as it conformed Accounting Standard Codification (“ASC”) 842 to the Company’s historical accounting under ASC 840. In March 2019, the FASB issued ASU 2019-01, “Leases (Topic 842): Codification Improvements,” which clarified the transition guidance related to interim disclosure requirements for the year of adoption. All of the ASC 842 ASUs are effective for annual reporting periods, and interim periods within those annual periods, beginning after December 15, 2018. The Company adopted these ASU’s on January 1, 2019 using a modified retrospective approach, which impacted the Company’s consolidated financial statements and related financial statement disclosures; specifically, the Company’s consolidated financial position as it relates to the required presentation for arrangements such as ground or other leases in which the Company is the lessee. However, the adoption of these ASUs did not have a material impact on the Company’s consolidated results of operations or cash flows. More specifically, the adoption of ASC 842 resulted in the Company recording operating lease assets and liabilities on January 1, 2019 with the difference between the operating lease assets and liabilities being record as an adjustment to the Company’s beginning accumulated loss balance. 2. Summary of Significant Accounting Policies (continued) The following table provides additional details by financial statement line item of the adjusted presentation in the Company’s consolidated financial position (in thousands): As Filed Effect of As Adjusted December 31, ASC 842 January 1, 2018 Adoption 2019 Assets held for sale, net $ 1,147,645 $ 403 $ 1,148,048 Total assets $ 2,705,887 $ 403 $ 2,706,290 Liabilities associated with assets held for sale $ 774,019 $ (2,779) $ 771,240 Total liabilities $ 1,763,961 $ (2,779) $ 1,761,182 Accumulated loss $ (233,847) $ 3,182 $ (230,665) Total equity $ 941,926 $ 3,182 $ 945,108 In May 2019, in connection with the MOB Sale, the Company disposed of substantially all the arrangements such as ground or other leases in which the Company is the lessee. In June 2018, the FASB issued ASU 2018-07, “Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting,” which expands the scope to include share-based payment transactions for acquiring goods and services from nonemployees. The amendments specify that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payments. The amendments also clarify that this ASU does not apply to share-based payments used to provide financing to the issuer or awards granted in conjunction with selling of goods or services to customers as a part of a contract accounted for under Revenue from Contracts with Customers (Topic 606). The ASU is effective for annual reporting periods, and interim periods within those annual periods, beginning after December 15, 2018. The Company adopted this ASU prospectively on January 1, 2019; the adoption of which did not have a material impact on the Company’s consolidated results of operations or cash flows. Recent Accounting Pronouncements — In June 2016, the FASB issued ASU No. 2016-13, “Measurement of Credit Losses on Financial Instruments (Topic 326),” which requires a new forward-looking expected loss model to be used for receivables, held-to-maturity debt, loans and other financial instruments. Previously, when credit losses were measured under current GAAP, an entity generally only considered past events and current conditions in measuring the incurred loss. The amendments eliminate the probable initial threshold for recognition of credit losses in current GAAP and, instead, reflect an entity’s current estimate of all expected credit losses over the life of the financial instrument. The ASU is effective for annual reporting periods, and interim periods within those annual periods, beginning after December 15, 2019. The Company has determined it will adopt this ASU on January 1, 2020 and does not expect the adoption of this ASU to have a material impact on the Company’s consolidated financial statements.

Revenue

Revenue	9 Months Ended
	Sep. 30, 2019
Revenue From Contract With Customer [Abstract]
Revenue	3. Revenue The following table presents disaggregated revenue related to the Company’s resident fees and services during the nine months ended September 30, 2019 and 2018: Nine Months Ended September 30, Number of Units Revenues (in millions) Percentage of Revenues Resident fees and services : 2019 2018 2019 2018 2019 2018 Independent living 2,261 2,261 $ 55.6 $ 53.4 25.8 % 25.9 % Assisted living 2,966 2,966 105.0 102.4 48.7 % 49.8 % Memory care 853 853 44.6 40.4 20.7 % 19.6 % Other revenues ― ― 10.3 9.6 4.8 % 4.7 % 6,080 6,080 $ 215.5 $ 205.8 100.0 % 100.0 %

Real Estate Assets, net

Real Estate Assets, net	9 Months Ended
	Sep. 30, 2019
Real Estate [Abstract]
Real Estate Assets, net	4. Real Estate Assets, net The gross carrying amount and accumulated depreciation of the Company’s real estate assets as of September 30, 2019 and December 31, 2018 are as follows, excluding assets held for sale (in thousands): September 30, December 31, 2019 2018 Land and land improvements $ 130,343 $ 130,133 Building and building improvements 1,476,912 1,475,789 Furniture, fixtures and equipment 84,201 81,666 Less: accumulated depreciation (269,157) (232,439) Real estate investment properties, net $ 1,422,299 $ 1,455,149

Assets and Associated Liabiliti

Assets and Associated Liabilities Held For Sale and Discontinued Operations	9 Months Ended
	Sep. 30, 2019
Real Estate Liabilities Associated With Assets Held For Development And Sale [Abstract]
Assets and Associated Liabilities Held For Sale and Discontinued Operations	5. Assets and Associated Liabilities Held For Sale and Discontinued Operations As part of executing on Possible Strategic Alternatives, the Company committed to a plan to sell a total of 70 properties, including: (1) six skilled nursing facilities located in Arkansas (“Perennial Communities”); (2) a portfolio of 53 MOBs, five post-acute care facilities and five acute care hospitals located across the U.S. (collectively, the “MOB/Healthcare Portfolio”); and (3) a post-acute care property located in Colorado (“ Welbrook Senior Living Grand Junction”). As such, the Company classified a total of 70 properties as held for sale. In December 2018, the Company entered into the MOB Sale Agreement related to the 55 MOBs and related properties within the MOB/Healthcare Portfolio that comprise the MOB Sale, for a gross sales price of $1.25 billion, subject to certain pro-rations and other adjustments as described in the MOB Sale Agreement. In May 2019, the Company completed the MOB Sale and recorded a gain for financial reporting purposes. 5. Assets and Associated Liabilities Held For Sale and Discontinued Operations (continued) In March 2019, the Company entered into the IRF Sale Agreement related to the four post-acute care properties within the MOB/Healthcare Portfolio that comprise the IRF Sale, for a gross sales price of $94 million, subject to certain pro-rations and other adjustments as described in the IRF Sale Agreement. In April 2019, the Company completed the IRF Sale and recorded a gain for financial reporting purposes. As of September 30, 2019, the 11 remaining properties classified as held for sale include: (1) the six Perennial Communities; (2) three acute care hospitals, including the Beaumont property for which the Company entered into the Beaumont Sale Agreement in July 2019, and one post-acute care facility within the MOB/Healthcare Portfolio; and (3) Welbrook Senior Living Grand Junction for which the Company entered into the Grand Junction Sale Agreement in October 2019. As of September 30, 2019, the assets held for sale and the liabilities associated with those assets held for sale consisted of the following (in thousands): As of September 30, 2019 MOB/Healthcare Portfolio Other Total Real estate investment properties, net $ 76,737 $ 51,339 $ 128,076 Intangibles, net 6,252 800 7,052 Deferred rent and lease incentives 3,622 6,040 9,662 Other assets 1,051 647 1,698 Restricted cash 86 145 231 Assets held for sale, net $ 87,748 $ 58,971 $ 146,719 Other liabilities $ 405 $ 634 $ 1,039 Accounts payable and accrued liabilities 37 ― 37 Liabilities associated with assets held for sale $ 442 $ 634 $ 1,076 As of December 31, 2018, the 70 properties classified as assets held for sale and the liabilities associated with those assets held for sale consisted of the following (in thousands): As of December 31, 2018 MOB/Healthcare Portfolio Other Total Real estate held for sale, net $ 952,656 $ 51,339 $ 1,003,995 Real estate under development 3,490 ― 3,490 Intangibles, net 82,417 800 83,217 Deferred rent and lease incentives 36,562 6,501 43,063 Other assets 11,425 182 11,607 Restricted cash 2,013 260 2,273 Assets held for sale, net $ 1,088,563 $ 59,082 $ 1,147,645 Mortgages and other notes payable, net $ 492,701 $ 8,097 $ 500,798 Credit facilities 212,731 34,778 247,509 Other liabilities 16,653 634 17,287 Accounts payable and accrued liabilities 8,425 ― 8,425 Liabilities associated with assets held for sale $ 730,510 $ 43,509 $ 774,019 5. Assets and Associated Liabilities Held For Sale and Discontinued Operations (continued) The Company classified the revenues and expenses related to the 63 properties comprising its MOB/Healthcare Portfolio as discontinued operations in the accompanying condensed consolidated statements of operations, as it believes the sale of these properties represents a strategic shift in the Company’s operations. The following table summarizes the Company’s income (loss) from discontinued operations for the quarter and nine months ended September 30, 2019 and 2018 (in thousands): Quarter Ended Nine Months Ended September 30, September 30, 2019 2018 2019 2018 Revenues: Rental income and related revenues $ 4,256 $ 28,458 $ 48,849 $ 85,345 Operating expenses: Property operating expenses 101 7,800 11,155 22,898 General and administrative 90 295 639 1,057 Asset management fees 254 3,031 4,758 9,094 Property management fees 9 707 1,249 2,899 Financing coordination fees ― ― ― 2,326 Depreciation and amortization ― 10,592 ― 31,956 Total operating expenses 454 22,425 17,801 70,230 Gain on sale of real estate ― ― 331,663 ― Operating income 3,802 6,033 362,711 15,115 Other income (expense): Interest and other income (expense) 22 3 33 107 Interest expense and loan cost amortization (1) (2) ― (8,652) (14,831) (24,678) Total other expense 22 (8,649) (14,798) (24,571) Income (loss) before income taxes 3,824 (2,616) 347,913 (9,456) Income tax expense 53 (18) (192) (55) Income (loss) from discontinued operations $ 3,877 $ (2,634) $ 347,721 $ (9,511) FOOTNOTES: (1) Interest expense and loan cost amortization directly relates to either: (1) expense on mortgages and other notes payable collateralized by properties classified as discontinued operations; or (2) expense on the Company’s credit facilities that is allocated based on the value of the properties, which are classified as discontinued operations and included in the credit facilities’ unencumbered pool of assets, and the related indebtedness is required to be repaid upon sale of the properties. (2) In connection with the IRF Sale and the MOB Sale, the Company wrote off approximately $3.3 million in unamortized loan costs as a loss on the early extinguishment of debt, which is included in interest expense and loan cost amortization herein for the nine months ended September 30, 2019.

Operating Leases

Operating Leases	9 Months Ended
	Sep. 30, 2019
Leases [Abstract]
Operating Leases	6. Operating Leases As of September 30, 2019, excluding the 11 remaining properties classified as held for sale, the Company owned 15 seniors housing properties that have been leased to tenants under triple-net operating leases. Under the terms of the Company’s triple-net lease agreements, each tenant is responsible for the payment of property taxes, general liability insurance, utilities, repairs and maintenance, including structural and roof maintenance expenses. Each tenant is expected to pay real estate taxes directly to the taxing authorities and, therefore, such amounts are not included in the Company’s condensed consolidated financial statements. However, if the tenant does not pay the real estate taxes, the Company would be liable for such amounts. As of September 30, 2019, the total annualized property tax assessed on these properties is approximately $3.2 million. As of September 30, 2019, excluding the 11 remaining properties classified as held for sale, the Company’s triple-net operating leases had a weighted average remaining lease term of 5.3 years based on annualized base rents expiring between 2022 and 2027, subject to the tenants’ options to extend the lease terms by an additional five years. In addition, certain tenants hold options to extend the lease terms for multiple five year periods, which are generally subject to similar terms and conditions provided under the initial lease term, including rent increases. The Company’s lease term is determined based on the non-cancellable lease term unless economic incentives make it reasonably certain that an extension option will be exercised, in which case the Company includes the extended lease term. The following are future minimum lease payments to be received under non-cancellable operating leases for the remainder of 2019, each of the next four years and thereafter, in the aggregate, as of September 30, 2019, excluding the 11 remaining properties classified as held for sale (in thousands): 2019 $ 6,906 2020 28,526 2021 29,128 2022 21,541 2023 20,912 Thereafter 50,948 $ 157,961 The above future minimum lease payments to be received exclude straight-line rent adjustments and base rent attributable to any renewal options exercised by the tenants in the future.

Variable Interest Entities

Variable Interest Entities	9 Months Ended
	Sep. 30, 2019
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Variable Interest Entities	7. Variable Interest Entities As of September 30, 2019 and December 31, 2018, the Company had three and eight subsidiaries, respectively, classified as VIEs. The change in the number of VIEs across periods resulted from three VIE properties being sold in connection with the MOB Sale as well as the repayment of two construction loans related to the Company’s completed developments . September 30, December 31, 2019 2018 Assets: Real estate investment properties, net $ 69,411 $ 146,341 Assets held for sale, net (1) $ — $ 39,601 Cash $ 549 $ 342 Other assets $ 598 $ 678 Deferred rent and lease incentives $ — $ 7,160 Restricted cash $ 111 $ 208 Liabilities: Mortgages and other notes payable, net $ 41,816 $ 102,578 Liabilities associated with assets held for sale (1) $ — $ 30,695 Accounts payable and accrued liabilities $ 1,139 $ 784 Other liabilities $ 236 $ 1,321 FOOTNOTE: (1) Refer to Note 5. “Assets and Associated Liabilities Held For Sale and Discontinued Operations” for additional information. The Company’s maximum exposure to loss as a result of its involvement with these VIEs is limited to its net investment in these entities which totaled approximately $25.6 million as of September 30, 2019. The Company’s exposure is limited because of the non-recourse nature of the borrowings of the VIEs. As of September 30, 2019, the Company had three subsidiaries which are classified as VIEs due to the following factors and circumstances: • One • Two The Company determined it is the primary beneficiary and holds a controlling financial interest in each of the aforementioned development entities due to its power to direct the activities that most significantly impact the economic performance of the entities, as well as its obligation to absorb the losses and its right to receive benefits from these entities that could potentially be significant to these entities. As such, the transactions and accounts of these VIEs are included in the accompanying condensed consolidated financial statements.

Indebtedness

Indebtedness	9 Months Ended
	Sep. 30, 2019
Debt Disclosure [Abstract]
Indebtedness	8. Indebtedness In May 2019, as further described in Note 1. “Organization,” the Company completed the MOB Sale and used a portion of the net cash proceeds from the MOB Sale to repay the Company’s unsecured credit facilities which, including indebtedness allocated to certain of the 55 properties comprising the MOB Sale, resulted in total repayments on the Company’s unsecured credit facilities as follows: (1) approximately $229.1 million on the Company’s senior unsecured revolving line of credit (“2014 Revolving Credit Facility”); (2) $175 million on the Company’s initial senior unsecured term loan facility (“First Term Loan Facility”); and (3) $275 million on the Company’s additional senior unsecured term loan facility (“Second Term Loan Facility” and, collectively with the 2014 Revolving Credit Facility and First Term Loan Facility, “2014 Credit Facilities”). Lastly, the Company strategically paid down approximately $28.6 million of indebtedness secured by other properties. In connection with the refinancing of the 2014 Credit Facilities and the strategic pay down of indebtedness, the Company wrote-off approximately $0.7 million in unamortized loan costs as a loss on the early extinguishment of debt, which is included in interest expense and loan cost amortization in the accompanying condensed consolidated statements of operations for the nine months ended September 30, 2019. Concurrently, in May 2019, the Company entered into new unsecured credit facilities, which include: (1) a $250 million senior unsecured revolving credit facility (“2019 Revolving Credit Facility”) and (2) a $265 million senior unsecured term loan facility (“2019 Term Loan Facility” and together with the 2019 Revolving Credit Facility, “2019 Credit Facilities”). The 2019 Revolving Credit Facility has an initial four-year term through May 2023, plus one 12-month extension option, and the 2019 Term Loan Facility has an initial five-year term through May 2024. The 2019 Credit Facilities bear interest based on 30-day LIBOR plus a spread that varies with the Company’s leverage ratio. In connection with the refinancing of the 2014 Credit Facilities, the Company paid financing coordination fees to the Advisor of approximately $5.2 million; refer to Note 9. “Related Party Arrangements” for additional information. In August 2019, the Company repaid the outstanding construction loans related to Wellmore of Lexington and Waterstone on Augusta of approximately $21.0 million and $18.7 million, respectively. In connection therewith, the Company wrote-off approximately $0.1 million in unamortized loan costs and paid exit fees of approximately $0.4 million, which are included in interest expense and loan cost amortization in the accompanying condensed consolidated statements of operations for the quarter and nine months ended September 30, 2019. These construction loans were scheduled to mature in September 2019 and September 2020, respectively. 8. Indebtedness (continued) The following table provides details of the Company’s indebtedness as of September 30, 2019 and December 31, 2018, excluding indebtedness associated with assets held for sale (in thousands): September 30, December 31, 2019 2018 Mortgages and other notes payable, net: Fixed rate debt $ 350,471 $ 358,843 Variable rate debt (1) (2) 85,628 174,046 Mortgages and other notes payable (3) 436,099 532,889 Premium (4) 153 184 Loan costs, net (1,329) (2,429) Total mortgages and other notes payable, net 434,923 530,644 Credit facilities, net: 2014 Revolving Credit Facility (1) (2) (5) ― ― First Term Loan Facility (2) ― 151,616 Second Term Loan Facility (1) (2) ― 275,000 2019 Revolving Credit Facility (1) (5) 20,000 ― 2019 Term Loan Facility (1) 265,000 ― Loan costs, net related to term loan facilities (2,168) (1,003) Total credit facilities, net 282,832 425,613 Total indebtedness, net $ 717,755 $ 956,257 FOOTNOTES: (1) As of September 30, 2019 and December 31, 2018, the Company had interest rate caps with notional amounts of approximately $273.0 million and $330.0 million, respectively. Refer to Note 10. “Derivative Financial Instruments” for additional information. (2) As of September 30, 2019, the Company did not have any interest rate swaps. As of December 31, 2018, the Company had interest rate swaps with notional amounts of approximately $151.6 million. These interest rate swaps were settled in connection with the refinancing of the credit facilities in May 2019. Refer to Note 10. “Derivative Financial Instruments” for additional information. (3) As of September 30, 2019 and December 31, 2018, the Company’s mortgages and other notes payable are collateralized by 35 and 37 properties, respectively, with total carrying value of approximately $0.7 billion and $0.8 billion, respectively. (4) Premium is reflective of the Company recording a mortgage note payable assumed at fair value on the respective acquisition date. (5) As of September 30, 2019 and December 31, 2018, the Company had undrawn availability under the applicable revolving credit facility of approximately $119.4 million and $14.7 million, respectively, based on the value of the properties in the unencumbered pool of assets supporting the loan, which includes certain assets held for sale. The following is a schedule of future principal payments and maturity for the Company’s total indebtedness for the remainder of 2019, each of the next four years and thereafter, in the aggregate, as of September 30, 2019 (in thousands): 2019 $ 24,344 2020 95,467 2021 11,352 2022 282,216 2023 42,873 Thereafter 265,000 $ 721,252 8. Indebtedness (continued) The following table provides details of the fair market value and carrying value of the Company’s indebtedness as of September 30, 2019 and December 31, 2018 (in millions): September 30, December 31, 2019 2018 Fair Value Carrying Value Fair Value Carrying Value Mortgages and other notes payable, net $ 440.5 $ 434.9 $ 528.7 $ 530.6 Credit facilities $ 285.0 $ 282.8 $ 426.6 $ 425.6 Indebtedness associated with assets held for sale $ ― $ ― $ 751.8 $ 748.3 These fair market values are based on current rates and spreads the Company would expect to obtain for similar borrowings. Since this methodology includes inputs that are less observable by the public and are not necessarily reflected in active markets, the measurement of the estimated fair values related to the Company’s mortgage notes payable is categorized as Level 3 on the three-level valuation hierarchy. The estimated fair value of accounts payable and accrued liabilities approximates the carrying value as of September 30, 2019 and December 31, 2018 because of the relatively short maturities of the obligations. All of the Company’s mortgage and construction loans contain customary financial covenants and ratios; including (but not limited to) the following: debt service coverage ratio, minimum occupancy levels, limitations on incurrence of additional indebtedness, etc. The credit facilities contain affirmative, negative, and financial covenants which are customary for loans of this type, including (but not limited to): (i) maximum leverage, (ii) minimum fixed charge coverage ratio, (iii) minimum consolidated net worth, (iv) restrictions on payments of cash distributions except if required by REIT requirements, (v) maximum secured indebtedness, (vi) maximum secured recourse debt, (vii) minimum unsecured interest coverage and (viii) limitations on certain types of investments and with respect to the pool of properties supporting borrowings under the credit facilities, minimum weighted average occupancy, and remaining lease terms, as well as property type, MSA, operator, and asset value concentration limits. The limitations on distributions generally include a limitation on the extent of allowable distributions, which are not to exceed the greater of 95% of adjusted FFO (as defined per the credit facilities) and the minimum amount of distributions required to maintain the Company’s REIT status. As of September 30, 2019, the Company was in compliance with all financial covenants.

Related Party Arrangements

Related Party Arrangements	9 Months Ended
	Sep. 30, 2019
Related Party Transactions [Abstract]
Related Party Arrangements	9. Related Party Arrangements In April 2018, the Company and CNL Healthcare Manager Corp. (“Property Manager”) agreed not to renew the property management agreement beyond its expiration date in June 2018. In addition, in May 2019, the Company’s board of directors approved the renewal of its advisory agreement with the Advisor through June 2020. During the quarter and nine months ended September 30, 2019, the Company paid approximately $0.1 million and $3.0 million, respectively, of cash distributions on restricted stock issued pursuant to the Advisor expense support agreement, which includes the special cash distribution paid in May 2019, as described further in Note 11. “Stockholders’ Equity.” During the quarter and nine months ended September 30, 2018, the Company paid approximately $0.2 million and $0.5 million, respectively, of cash distributions on restricted stock issued pursuant to the Advisor expense support agreement. These amounts have been recognized as compensation expense and included in general and administrative expenses in the accompanying condensed consolidated statements of operations. The expenses and fees incurred by and reimbursable to the Company’s related parties, including amounts included in income (loss) from discontinued operations for the quarter and nine months ended September 30, 2019 and 2018, and related amounts unpaid as of September 30, 2019 and December 31, 2018 are as follows (in thousands): Quarter ended Nine Months Ended Unpaid amounts as of (1) September 30, September 30, September 30, December 31, 2019 2018 2019 2018 2019 2018 Reimbursable expenses: Operating expenses (2) $ 1,097 $ 1,444 $ 3,836 $ 4,672 $ 557 $ 722 1,097 1,444 3,836 4,672 557 722 Investment services fees (3) — — — 60 — — Financing coordination fees (4) — — 5,351 2,326 — — Property management fees (5) — — — 2,323 — — Asset management fees 4,844 7,593 18,529 22,791 1,614 2,533 Disposition fees (6) — — 2,957 58 — — $ 5,941 $ 9,037 $ 30,673 $ 32,230 $ 2,171 $ 3,255 FOOTNOTES: (1) Amounts are recorded as due to related parties in the accompanying condensed consolidated balance sheets. (2) Amounts are recorded as general and administrative expenses in the accompanying condensed consolidated statements of operations unless such amounts represent prepaid expenses, which are capitalized in the accompanying condensed consolidated balance sheets. (3) For the quarter and nine months ended September 30, 2019, the Company did not incur any investment services fees. For the nine months ended September 30, 2018, the Company incurred investment service fees of approximately $0.1 million, which were capitalized and included in real estate assets, net in the accompanying condensed consolidated balance sheets. (4) For the nine months ended September 30, 2019, the Company incurred financing coordination fees of approximately $5.4 million primarily related to the 2019 Credit Facilities of which approximately $3.5 million were capitalized in the accompanying condensed consolidated balance sheets. For the nine months ended September 30, 2018, the Company incurred financing coordination fees of approximately $2.3 million, which were expensed as incurred. Financing coordination fees associated with the refinancing of debt are either expensed or capitalized based on whether such refinancings are determined to represent loan modifications or loan extinguishments for accounting purposes. (5) No (6) Amounts are recorded as a reduction to gain on sale of real estate in the accompanying consolidated statements of operations.

Derivative Financial Instrument

Derivative Financial Instruments	9 Months Ended
	Sep. 30, 2019
Derivative Instruments And Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	10. Derivative Financial Instruments The following summarizes the terms of the Company’s, or its equity method investment’s, derivative financial instruments and the corresponding asset (liability) as of September 30, 2019 and December 31, 2018 (in thousands): Fair value asset (liability) as of Notional Amount Strike (1) Credit Spread (1) Trade date Forward date Maturity date September 30, 2019 December 31, 2018 $ ― (2) (3) 2.3 % 2.4 % 9/12/2014 8/1/2015 7/15/2019 $ ― $ 168 $ ― (2) 1.6 % 2.0 % 12/23/2014 12/19/2014 2/19/2019 $ ― $ 220 $ ― (2) (3) 1.7 % 2.0 % 1/9/2015 12/10/2015 12/22/2019 $ ― $ 966 $ ― (4) 2.3 % ― % 8/29/2017 8/29/2017 9/1/2019 $ ― $ 247 $ 223,000 (3) (4) 3.0 % ― % 3/28/2018 11/30/2018 12/19/2019 $ ― $ 44 $ ― (3) (4) 3.0 % ― % 3/28/2018 7/10/2018 12/19/2019 $ ― $ 6 $ ― (3) (4) 3.0 % ― % 3/28/2018 2/19/2019 12/19/2019 $ ― $ 19 $ ― (3) (4) 3.0 % ― % 5/4/2018 5/4/2018 12/19/2019 $ ― $ 6 $ 10,500 (4) 3.3 % ― % 2/28/2019 3/1/2019 9/1/2021 $ ― $ ― $ 50,000 (4) 2.3 % ― % 8/16/2019 9/1/2019 12/31/2020 $ 5 $ ― FOOTNOTES: (1) The all-in rates are equal to the sum of the Strike and Credit Spread detailed above. (2) Amounts related to interest rate swaps held by the Company which are recorded at fair value and included in either other assets or other liabilities in the accompanying condensed consolidated balance sheets. (3) All or a portion of these derivative financial instruments were settled in connection with the pay down of the respective loan balances. (4) Amounts related to the interest rate caps held by the Company, or its equity method investment, which are recorded at fair value and included in other assets in the accompanying condensed consolidated balance sheets. Although the Company has determined that the majority of the inputs used to value its derivative financial instruments fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with its derivatives utilize Level 3 inputs, such as estimates of current credit spreads, to evaluate the likelihood of default by the Company and its counterparties. The Company has assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its derivative financial instruments and has determined that the credit valuation adjustments on the overall valuation adjustments are not significant to the overall valuation of its derivative financial instruments. As a result, the Company determined that its derivative financial instruments valuation in its entirety is classified in Level 2 of the fair value hierarchy. Determining fair value requires management to make certain estimates and judgments. Changes in assumptions could have a positive or negative impact on the estimated fair values of such instruments which could, in turn, impact the Company’s or its equity method investment’s results of operations.

Equity

Equity	9 Months Ended
	Sep. 30, 2019
Equity [Abstract]
Equity	11. Equity Stockholders’ Equity: Distribution Reinvestment Plan — In July 2018, in light of the Company’s decision to proceed with the exploration of Possible Strategic Alternatives, the Company suspended the Reinvestment Plan and the Redemption Plan. As such, there were no such proceeds received for the quarter and nine months ended September 30, 2019. As a result of the suspension of the Reinvestment Plan in July 2018, the Company did not receive any proceeds through its Reinvestment Plan subsequent to June 2018. For the nine months ended September 30, 2018, the Company received proceeds through its Reinvestment Plan of approximately $22.0 million. Distributions — During the quarter and nine months ended September 30, 2019, the Company declared cash distributions of approximately $8.9 million and $386.0 million, respectively, which included a special cash distribution funded in May 2019 with proceeds from the sale of real estate and all of which were paid in cash to stockholders. During the quarter and nine months ended September 30, 2018, the Company declared cash distributions of approximately $20.2 million and $60.8 million, respectively, of which approximately $20.2 million and $38.8 million, respectively, were paid in cash to stockholders. As a result of the suspension of the Reinvestment Plan in July 2018, none of the cash distributions were reinvested pursuant to the Reinvestment Plan subsequent to June 2018. For the nine months ended September 30, 2018, the Company received proceeds of approximately $32.0 million through the Reinvestment Plan. No amounts distributed to stockholders during the quarter and nine months ended September 30, 2019 and 2018 were required to be or have been treated as a return of capital for purposes of calculating the stockholders’ return on their invested capital as described in the advisory agreement. Redemptions — In July 2018, in light of the Company’s decision to proceed with the exploration of Possible Strategic Alternatives, the Company suspended the Reinvestment Plan and the Redemption Plan. No requests for redemptions have been accepted subsequent to suspension of the Redemption Plan. As such, there were no requests for the redemption of common stock during the quarter and nine months ended September 30, 2019. During the quarter and nine months ended September 30, 2018, the Company received requests for the redemption of common stock of approximately $4.8 million and $44.8 million, respectively. For the quarter ended September 30, 2018, no requests for the redemption of common stock were approved. For the nine months ended September 30, 2018, $28.3 million of the requests were approved for redemption at an average price of $10.14 per share. During the quarter and nine months ended September 30, 2018, as a result of the Redemption Plan being suspended, approximately $16.4 million in unsatisfied redemption requests were placed in the redemption queue and will remain there until such time, if at all, that the Company’s board of directors reinstates the Redemption Plan. Unless the Redemption Plan is reinstated by the Company’s board of directors, the Company will not as a general matter, accept or otherwise process any additional redemption requests received after July 11, 2018. There can be no guarantee that the Redemption Plan will be reinstated by the Company’s board of directors. 11. Equity (continued) Other comprehensive income (loss) — The following table reflects the effect of derivative financial instruments held by the Company, or its equity method investment, and included in the condensed consolidated statements of comprehensive income (loss) for the quarter and nine months ended September 30, 2019 and 2018 (in thousands): Derivative financial instruments Gain (loss) recognized in other comprehensive loss on derivative financial instruments Location of gain (loss) reclassified into earnings Gain (loss) reclassified from accumulated other comprehensive loss into earnings Quarter Ended Quarter Ended September 30, September 30, 2019 2018 2019 2018 Interest rate swaps $ ― $ (205) Interest expense and loan cost amortization $ ― $ 979 Interest rate caps 32 (40) Interest expense and loan cost amortization (25) (581) Reclassification of interest rate swaps upon derecognition ― 14 Interest expense and loan cost amortization ― (14) Interest rate cap held by unconsolidated joint venture (1) ― Interest expense and loan cost amortization 1 ― Total $ 31 $ (231) $ (24) $ 384 Derivative financial instruments Gain (loss) recognized in other comprehensive loss on derivative financial instruments Location of gain (loss) reclassified into earnings Gain (loss) reclassified from accumulated other comprehensive loss into earnings Nine Months Ended Nine Months Ended September 30, September 30, 2019 2018 2019 2018 Interest rate swaps $ (336) $ 2,102 Interest expense and loan cost amortization $ 813 $ 1,299 Interest rate caps (668) 1,176 Interest expense and loan cost amortization (162) (1,500) Reclassification of interest rate swaps upon derecognition (509) 267 Interest expense and loan cost amortization 509 (267) Reclassification of interest rate caps upon derecognition 265 ― Interest expense and loan cost amortization (265) ― Interest rate cap held by unconsolidated joint venture 11 ― Interest expense and loan cost amortization (11) ― Total $ (1,237) $ 3,545 $ 884 $ (468)

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2019
Income Tax Disclosure [Abstract]
Income Taxes	12. Income Taxes The accompanying condensed consolidated financial statements include an interim tax provision for the quarter and nine months ended September 30, 2019 and 2018. The Company recorded a total provision for income taxes of approximately $0.7 million and $1.9 million for the quarter and nine months ended September 30, 2019, respectively, and $0.9 million and $2.4 million for the quarter and nine months ended September 30, 2018, respectively. Of the total provision for income taxes for the quarter and nine months ended September 30, 2019, approximately $0.1 million and $0.4 million, respectively, represent current income tax expense, and approximately $0.5 million and $1.5 million, respectively, represent a decrease to the Company’s net deferred tax assets which is primarily due to the utilization of a portion of the Company’s TRS’s federal and state net operating loss carry-forwards. Of the total provision for income taxes for the quarter and nine months ended September 30, 2018, approximately $0.2 million and $0.4 million, respectively, represent current income tax expense, and approximately $0.7 million and $2.0 million, respectively, represent a decrease to the Company’s net deferred tax assets which is primarily due to the utilization of a portion of the Company’s TRS’s federal and state net operating loss carry-forwards.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2019
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	13. Commitments and Contingencies From time to time, the Company may be a party to legal proceedings in the ordinary course of, or incidental to the normal course of, its business, including proceedings to enforce its contractual or statutory rights. While the Company cannot predict the outcome of these legal proceedings with certainty, based upon currently available information, the Company does not believe the final outcome of any pending or threatened legal proceeding will have a material adverse effect on its results of operations or financial condition. As a result of the Company’s completed seniors housing developments continuing to move towards or achieving stabilization, the Company monitors the lease-up of these properties to determine whether the established performance metrics have been met as of each reporting period. The Company has six remaining promoted interest agreements with third-party developers pursuant to which certain operating targets have been established that, upon meeting such targets, result in the developer being entitled to additional payments based on enumerated percentages of the assumed net proceeds of a deemed sale, subject to achievement of an established internal rate of return on the Company’s investment in the development. As of September 30, 2019, one property had met its established performance metrics, but no promoted interest obligation was currently owed pursuant to the distribution calculation; whereas for the remaining five promoted interest agreements, the established performance metrics were not met nor probable of being met as of September 30, 2019. The Company’s Advisor has approximately 1.3 million contingently issuable restricted stock shares for financial reporting purposes that were issued pursuant to the Advisor expense support agreement. Refer to Note 9. “Related Party Arrangements” for information on distributions declared related to these restricted stock shares.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2019
Subsequent Events [Abstract]
Subsequent Events	14. Subsequent Events In October 2019, the Company completed the Beaumont Sale and received net sales proceeds of approximately $33.2 million. The net sales proceeds from the Beaumont Sale exceeded the net carrying value of the property. In October 2019, the Company entered into the Grand Junction Sale Agreement for a gross sales price of $5.9 million, subject to certain pro-rations and other adjustments as described in the Grand Junction Sale Agreement. The closing of the Grand Junction Sale is subject to the completion of customary closing conditions, governmental and other third-party consents. The anticipated net sales proceeds from the Grand Junction Sale are expected to approximate the net carrying value of the property.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2019
Accounting Policies [Abstract]
Basis of Presentation and Consolidation	Basis of Presentation and Consolidation — The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and note disclosures required by generally accepted accounting principles in the U.S. (“GAAP”). The unaudited condensed consolidated financial statements reflect all normal recurring adjustments, which, in the opinion of management, are necessary for the fair statement of the Company’s results for the interim period presented. Operating results for the quarter and nine months ended September 30, 2019 may not be indicative of the results that may be expected for the year ending December 31, 2019. Amounts as of December 31, 2018 included in the unaudited condensed consolidated financial statements have been derived from audited consolidated financial statements as of that date but do not include all disclosures required by GAAP. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 (“Annual Report”). The accompanying unaudited condensed consolidated financial statements include the Company’s accounts, the accounts of wholly owned subsidiaries or subsidiaries for which the Company has a controlling interest, the accounts of variable interest entities (“VIEs”) in which the Company is the primary beneficiary, and the accounts of other subsidiaries over which the Company has a controlling financial interest. All material intercompany accounts and transactions have been eliminated in consolidation. 2. Summary of Significant Accounting Policies (continued) In accordance with the guidance for the consolidation of a VIE, the Company is required to identify entities for which control is achieved through means other than voting rights and to determine the primary beneficiary of its VIEs. The Company qualitatively assesses whether it is the primary beneficiary of a VIE and considers various factors including, but not limited to, the design of the entity, its organizational structure including decision-making ability and financial agreements, its ability and the rights of others to participate in policy making decisions, as well as its ability to replace the VIE manager and/or liquidate the entity.
Reclassifications	Reclassifications – Certain amounts in the prior year’s condensed consolidated statement of cash flows have been reclassified to conform to the current year’s presentation, primarily related to classification of certain properties as discontinued operations, with no effect on the other previously reported consolidated financial statements.
Use of Estimates	Use of Estimates — The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements, the reported amounts of revenues and expenses during the reporting periods and the disclosure of contingent liabilities. For example, significant assumptions are made in the analysis of real estate impairments, the valuation of contingent assets and liabilities, and the valuation of restricted common stock (“Restricted Stock”) shares issued to the Advisor. Accordingly, actual results could differ from those estimates.
Adopted Accounting Pronouncements	Adopted Accounting Pronouncements — In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016-02, “Leases (Topic 842): Accounting for Leases,” which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e., lessees and lessors). The ASU requires lessees to recognize assets and liabilities on the balance sheet for the rights and obligations created by all leases with terms of more than 12 months. The ASU further modifies lessors’ classification criteria for leases and the accounting for sales-type and direct financing leases. The ASU also requires qualitative and quantitative disclosures designed to give financial statement users additional information on the amount, timing, and uncertainty of cash flows arising from leases. In July 2018, the FASB issued ASU 2018-11, “Leases (Topic 842): Targeted Improvements,” which includes a practical expedient for lessors that allows them to elect to not separate lease and non-lease components in a contract for the purpose of revenue recognition and disclosure if certain criteria are met. The Company elected this practical expedient and applied the guidance to all of the leases that qualified under the established criteria. In December 2018, the FASB issued ASU 2018-20, “Leases (Topic 842): Narrow-Scope Improvements for Lessors,” which addressed challenges encountered in determining certain lessor costs paid by the lessee directly to third parties by allowing lessors to exclude these costs from its variable lease payments. This amendment did not have a material impact on the Company’s financial statements and related disclosures as it conformed Accounting Standard Codification (“ASC”) 842 to the Company’s historical accounting under ASC 840. In March 2019, the FASB issued ASU 2019-01, “Leases (Topic 842): Codification Improvements,” which clarified the transition guidance related to interim disclosure requirements for the year of adoption. All of the ASC 842 ASUs are effective for annual reporting periods, and interim periods within those annual periods, beginning after December 15, 2018. The Company adopted these ASU’s on January 1, 2019 using a modified retrospective approach, which impacted the Company’s consolidated financial statements and related financial statement disclosures; specifically, the Company’s consolidated financial position as it relates to the required presentation for arrangements such as ground or other leases in which the Company is the lessee. However, the adoption of these ASUs did not have a material impact on the Company’s consolidated results of operations or cash flows. More specifically, the adoption of ASC 842 resulted in the Company recording operating lease assets and liabilities on January 1, 2019 with the difference between the operating lease assets and liabilities being record as an adjustment to the Company’s beginning accumulated loss balance. 2. Summary of Significant Accounting Policies (continued) The following table provides additional details by financial statement line item of the adjusted presentation in the Company’s consolidated financial position (in thousands): As Filed Effect of As Adjusted December 31, ASC 842 January 1, 2018 Adoption 2019 Assets held for sale, net $ 1,147,645 $ 403 $ 1,148,048 Total assets $ 2,705,887 $ 403 $ 2,706,290 Liabilities associated with assets held for sale $ 774,019 $ (2,779) $ 771,240 Total liabilities $ 1,763,961 $ (2,779) $ 1,761,182 Accumulated loss $ (233,847) $ 3,182 $ (230,665) Total equity $ 941,926 $ 3,182 $ 945,108 In May 2019, in connection with the MOB Sale, the Company disposed of substantially all the arrangements such as ground or other leases in which the Company is the lessee. In June 2018, the FASB issued ASU 2018-07, “Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting,” which expands the scope to include share-based payment transactions for acquiring goods and services from nonemployees. The amendments specify that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payments. The amendments also clarify that this ASU does not apply to share-based payments used to provide financing to the issuer or awards granted in conjunction with selling of goods or services to customers as a part of a contract accounted for under Revenue from Contracts with Customers (Topic 606). The ASU is effective for annual reporting periods, and interim periods within those annual periods, beginning after December 15, 2018. The Company adopted this ASU prospectively on January 1, 2019; the adoption of which did not have a material impact on the Company’s consolidated results of operations or cash flows.
Recent Accounting Pronouncements	Recent Accounting Pronouncements — In June 2016, the FASB issued ASU No. 2016-13, “Measurement of Credit Losses on Financial Instruments (Topic 326),” which requires a new forward-looking expected loss model to be used for receivables, held-to-maturity debt, loans and other financial instruments. Previously, when credit losses were measured under current GAAP, an entity generally only considered past events and current conditions in measuring the incurred loss. The amendments eliminate the probable initial threshold for recognition of credit losses in current GAAP and, instead, reflect an entity’s current estimate of all expected credit losses over the life of the financial instrument. The ASU is effective for annual reporting periods, and interim periods within those annual periods, beginning after December 15, 2019. The Company has determined it will adopt this ASU on January 1, 2020 and does not expect the adoption of this ASU to have a material impact on the Company’s consolidated financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2019
Adoption of ASC 842
Schedule of Adjusted Consolidated Balance Sheet	The following table provides additional details by financial statement line item of the adjusted presentation in the Company’s consolidated financial position (in thousands): As Filed Effect of As Adjusted December 31, ASC 842 January 1, 2018 Adoption 2019 Assets held for sale, net $ 1,147,645 $ 403 $ 1,148,048 Total assets $ 2,705,887 $ 403 $ 2,706,290 Liabilities associated with assets held for sale $ 774,019 $ (2,779) $ 771,240 Total liabilities $ 1,763,961 $ (2,779) $ 1,761,182 Accumulated loss $ (233,847) $ 3,182 $ (230,665) Total equity $ 941,926 $ 3,182 $ 945,108

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Sep. 30, 2019
Revenue From Contract With Customer [Abstract]
Summary of Disaggregation of Revenue	The following table presents disaggregated revenue related to the Company’s resident fees and services during the nine months ended September 30, 2019 and 2018: Nine Months Ended September 30, Number of Units Revenues (in millions) Percentage of Revenues Resident fees and services : 2019 2018 2019 2018 2019 2018 Independent living 2,261 2,261 $ 55.6 $ 53.4 25.8 % 25.9 % Assisted living 2,966 2,966 105.0 102.4 48.7 % 49.8 % Memory care 853 853 44.6 40.4 20.7 % 19.6 % Other revenues ― ― 10.3 9.6 4.8 % 4.7 % 6,080 6,080 $ 215.5 $ 205.8 100.0 % 100.0 %

Real Estate Assets, net (Tables

Real Estate Assets, net (Tables)	9 Months Ended
	Sep. 30, 2019
Real Estate [Abstract]
Schedule of Real Estate Investment Properties Excluding Assets Held For Sale	The gross carrying amount and accumulated depreciation of the Company’s real estate assets as of September 30, 2019 and December 31, 2018 are as follows, excluding assets held for sale (in thousands): September 30, December 31, 2019 2018 Land and land improvements $ 130,343 $ 130,133 Building and building improvements 1,476,912 1,475,789 Furniture, fixtures and equipment 84,201 81,666 Less: accumulated depreciation (269,157) (232,439) Real estate investment properties, net $ 1,422,299 $ 1,455,149

Assets and Associated Liabili_2

Assets and Associated Liabilities Held For Sale and Discontinued Operations (Tables)	9 Months Ended
	Sep. 30, 2019
Real Estate Liabilities Associated With Assets Held For Development And Sale [Abstract]
Schedule of Assets Classified as Held for Sale and Liabilities Associated with Those Assets Held for Sale	As of September 30, 2019, the assets held for sale and the liabilities associated with those assets held for sale consisted of the following (in thousands): As of September 30, 2019 MOB/Healthcare Portfolio Other Total Real estate investment properties, net $ 76,737 $ 51,339 $ 128,076 Intangibles, net 6,252 800 7,052 Deferred rent and lease incentives 3,622 6,040 9,662 Other assets 1,051 647 1,698 Restricted cash 86 145 231 Assets held for sale, net $ 87,748 $ 58,971 $ 146,719 Other liabilities $ 405 $ 634 $ 1,039 Accounts payable and accrued liabilities 37 ― 37 Liabilities associated with assets held for sale $ 442 $ 634 $ 1,076 As of December 31, 2018, the 70 properties classified as assets held for sale and the liabilities associated with those assets held for sale consisted of the following (in thousands): As of December 31, 2018 MOB/Healthcare Portfolio Other Total Real estate held for sale, net $ 952,656 $ 51,339 $ 1,003,995 Real estate under development 3,490 ― 3,490 Intangibles, net 82,417 800 83,217 Deferred rent and lease incentives 36,562 6,501 43,063 Other assets 11,425 182 11,607 Restricted cash 2,013 260 2,273 Assets held for sale, net $ 1,088,563 $ 59,082 $ 1,147,645 Mortgages and other notes payable, net $ 492,701 $ 8,097 $ 500,798 Credit facilities 212,731 34,778 247,509 Other liabilities 16,653 634 17,287 Accounts payable and accrued liabilities 8,425 ― 8,425 Liabilities associated with assets held for sale $ 730,510 $ 43,509 $ 774,019
Summary of Income (Loss) from Discontinued Operations	The following table summarizes the Company’s income (loss) from discontinued operations for the quarter and nine months ended September 30, 2019 and 2018 (in thousands): Quarter Ended Nine Months Ended September 30, September 30, 2019 2018 2019 2018 Revenues: Rental income and related revenues $ 4,256 $ 28,458 $ 48,849 $ 85,345 Operating expenses: Property operating expenses 101 7,800 11,155 22,898 General and administrative 90 295 639 1,057 Asset management fees 254 3,031 4,758 9,094 Property management fees 9 707 1,249 2,899 Financing coordination fees ― ― ― 2,326 Depreciation and amortization ― 10,592 ― 31,956 Total operating expenses 454 22,425 17,801 70,230 Gain on sale of real estate ― ― 331,663 ― Operating income 3,802 6,033 362,711 15,115 Other income (expense): Interest and other income (expense) 22 3 33 107 Interest expense and loan cost amortization (1) (2) ― (8,652) (14,831) (24,678) Total other expense 22 (8,649) (14,798) (24,571) Income (loss) before income taxes 3,824 (2,616) 347,913 (9,456) Income tax expense 53 (18) (192) (55) Income (loss) from discontinued operations $ 3,877 $ (2,634) $ 347,721 $ (9,511) FOOTNOTES: (1) Interest expense and loan cost amortization directly relates to either: (1) expense on mortgages and other notes payable collateralized by properties classified as discontinued operations; or (2) expense on the Company’s credit facilities that is allocated based on the value of the properties, which are classified as discontinued operations and included in the credit facilities’ unencumbered pool of assets, and the related indebtedness is required to be repaid upon sale of the properties. (2) In connection with the IRF Sale and the MOB Sale, the Company wrote off approximately $3.3 million in unamortized loan costs as a loss on the early extinguishment of debt, which is included in interest expense and loan cost amortization herein for the nine months ended September 30, 2019.

Operating Leases (Tables)

Operating Leases (Tables)	9 Months Ended
	Sep. 30, 2019
Leases [Abstract]
Schedule of Future Minimum Lease Payments to be Received Under Non-Cancellable Operating Leases Excluding Properties Classified as Discontinued Operations	The following are future minimum lease payments to be received under non-cancellable operating leases for the remainder of 2019, each of the next four years and thereafter, in the aggregate, as of September 30, 2019, excluding the 11 remaining properties classified as held for sale (in thousands): 2019 $ 6,906 2020 28,526 2021 29,128 2022 21,541 2023 20,912 Thereafter 50,948 $ 157,961

Variable Interest Entities (Tab

Variable Interest Entities (Tables)	9 Months Ended
	Sep. 30, 2019
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Aggregate Carrying Amount and Major Classifications of Consolidated Assets and Liabilities	The aggregate carrying amount and major classifications of the consolidated assets that can be used to settle obligations of the VIEs and liabilities of the consolidated VIEs that are non-recourse to the Company as of September 30, 2019 and December 31, 2018 are as follows (in thousands): September 30, December 31, 2019 2018 Assets: Real estate investment properties, net $ 69,411 $ 146,341 Assets held for sale, net (1) $ — $ 39,601 Cash $ 549 $ 342 Other assets $ 598 $ 678 Deferred rent and lease incentives $ — $ 7,160 Restricted cash $ 111 $ 208 Liabilities: Mortgages and other notes payable, net $ 41,816 $ 102,578 Liabilities associated with assets held for sale (1) $ — $ 30,695 Accounts payable and accrued liabilities $ 1,139 $ 784 Other liabilities $ 236 $ 1,321 FOOTNOTE: (1) Refer to Note 5. “Assets and Associated Liabilities Held For Sale and Discontinued Operations” for additional information.

Indebtedness (Tables)

Indebtedness (Tables)	9 Months Ended
	Sep. 30, 2019
Debt Disclosure [Abstract]
Details of Indebtedness, Excluding Indebtedness Associated with Assets Held for Sale	The following table provides details of the Company’s indebtedness as of September 30, 2019 and December 31, 2018, excluding indebtedness associated with assets held for sale (in thousands): September 30, December 31, 2019 2018 Mortgages and other notes payable, net: Fixed rate debt $ 350,471 $ 358,843 Variable rate debt (1) (2) 85,628 174,046 Mortgages and other notes payable (3) 436,099 532,889 Premium (4) 153 184 Loan costs, net (1,329) (2,429) Total mortgages and other notes payable, net 434,923 530,644 Credit facilities, net: 2014 Revolving Credit Facility (1) (2) (5) ― ― First Term Loan Facility (2) ― 151,616 Second Term Loan Facility (1) (2) ― 275,000 2019 Revolving Credit Facility (1) (5) 20,000 ― 2019 Term Loan Facility (1) 265,000 ― Loan costs, net related to term loan facilities (2,168) (1,003) Total credit facilities, net 282,832 425,613 Total indebtedness, net $ 717,755 $ 956,257 FOOTNOTES: (1) As of September 30, 2019 and December 31, 2018, the Company had interest rate caps with notional amounts of approximately $273.0 million and $330.0 million, respectively. Refer to Note 10. “Derivative Financial Instruments” for additional information. (2) As of September 30, 2019, the Company did not have any interest rate swaps. As of December 31, 2018, the Company had interest rate swaps with notional amounts of approximately $151.6 million. These interest rate swaps were settled in connection with the refinancing of the credit facilities in May 2019. Refer to Note 10. “Derivative Financial Instruments” for additional information. (3) As of September 30, 2019 and December 31, 2018, the Company’s mortgages and other notes payable are collateralized by 35 and 37 properties, respectively, with total carrying value of approximately $0.7 billion and $0.8 billion, respectively. (4) Premium is reflective of the Company recording a mortgage note payable assumed at fair value on the respective acquisition date. (5) As of September 30, 2019 and December 31, 2018, the Company had undrawn availability under the applicable revolving credit facility of approximately $119.4 million and $14.7 million, respectively, based on the value of the properties in the unencumbered pool of assets supporting the loan, which includes certain assets held for sale.
Schedule of Maturities of Indebtedness	The following is a schedule of future principal payments and maturity for the Company’s total indebtedness for the remainder of 2019, each of the next four years and thereafter, in the aggregate, as of September 30, 2019 (in thousands): 2019 $ 24,344 2020 95,467 2021 11,352 2022 282,216 2023 42,873 Thereafter 265,000 $ 721,252
Schedule of Fair Market Value and Carrying Value of Indebtedness	The following table provides details of the fair market value and carrying value of the Company’s indebtedness as of September 30, 2019 and December 31, 2018 (in millions): September 30, December 31, 2019 2018 Fair Value Carrying Value Fair Value Carrying Value Mortgages and other notes payable, net $ 440.5 $ 434.9 $ 528.7 $ 530.6 Credit facilities $ 285.0 $ 282.8 $ 426.6 $ 425.6 Indebtedness associated with assets held for sale $ ― $ ― $ 751.8 $ 748.3

Related Party Arrangements (Tab

Related Party Arrangements (Tables)	9 Months Ended
	Sep. 30, 2019
Related Party Transactions [Abstract]
Schedule of Fees, Reimbursable Expenses and Related Amounts Unpaid to Related Parties	The expenses and fees incurred by and reimbursable to the Company’s related parties, including amounts included in income (loss) from discontinued operations for the quarter and nine months ended September 30, 2019 and 2018, and related amounts unpaid as of September 30, 2019 and December 31, 2018 are as follows (in thousands): Quarter ended Nine Months Ended Unpaid amounts as of (1) September 30, September 30, September 30, December 31, 2019 2018 2019 2018 2019 2018 Reimbursable expenses: Operating expenses (2) $ 1,097 $ 1,444 $ 3,836 $ 4,672 $ 557 $ 722 1,097 1,444 3,836 4,672 557 722 Investment services fees (3) — — — 60 — — Financing coordination fees (4) — — 5,351 2,326 — — Property management fees (5) — — — 2,323 — — Asset management fees 4,844 7,593 18,529 22,791 1,614 2,533 Disposition fees (6) — — 2,957 58 — — $ 5,941 $ 9,037 $ 30,673 $ 32,230 $ 2,171 $ 3,255 FOOTNOTES: (1) Amounts are recorded as due to related parties in the accompanying condensed consolidated balance sheets. (2) Amounts are recorded as general and administrative expenses in the accompanying condensed consolidated statements of operations unless such amounts represent prepaid expenses, which are capitalized in the accompanying condensed consolidated balance sheets. (3) For the quarter and nine months ended September 30, 2019, the Company did not incur any investment services fees. For the nine months ended September 30, 2018, the Company incurred investment service fees of approximately $0.1 million, which were capitalized and included in real estate assets, net in the accompanying condensed consolidated balance sheets. (4) For the nine months ended September 30, 2019, the Company incurred financing coordination fees of approximately $5.4 million primarily related to the 2019 Credit Facilities of which approximately $3.5 million were capitalized in the accompanying condensed consolidated balance sheets. For the nine months ended September 30, 2018, the Company incurred financing coordination fees of approximately $2.3 million, which were expensed as incurred. Financing coordination fees associated with the refinancing of debt are either expensed or capitalized based on whether such refinancings are determined to represent loan modifications or loan extinguishments for accounting purposes. (5) No (6) Amounts are recorded as a reduction to gain on sale of real estate in the accompanying consolidated statements of operations.

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2019
Derivative Instruments And Hedging Activities Disclosure [Abstract]
Summary of Derivative Financial Instruments and Corresponding Asset (Liability)	The following summarizes the terms of the Company’s, or its equity method investment’s, derivative financial instruments and the corresponding asset (liability) as of September 30, 2019 and December 31, 2018 (in thousands): Fair value asset (liability) as of Notional Amount Strike (1) Credit Spread (1) Trade date Forward date Maturity date September 30, 2019 December 31, 2018 $ ― (2) (3) 2.3 % 2.4 % 9/12/2014 8/1/2015 7/15/2019 $ ― $ 168 $ ― (2) 1.6 % 2.0 % 12/23/2014 12/19/2014 2/19/2019 $ ― $ 220 $ ― (2) (3) 1.7 % 2.0 % 1/9/2015 12/10/2015 12/22/2019 $ ― $ 966 $ ― (4) 2.3 % ― % 8/29/2017 8/29/2017 9/1/2019 $ ― $ 247 $ 223,000 (3) (4) 3.0 % ― % 3/28/2018 11/30/2018 12/19/2019 $ ― $ 44 $ ― (3) (4) 3.0 % ― % 3/28/2018 7/10/2018 12/19/2019 $ ― $ 6 $ ― (3) (4) 3.0 % ― % 3/28/2018 2/19/2019 12/19/2019 $ ― $ 19 $ ― (3) (4) 3.0 % ― % 5/4/2018 5/4/2018 12/19/2019 $ ― $ 6 $ 10,500 (4) 3.3 % ― % 2/28/2019 3/1/2019 9/1/2021 $ ― $ ― $ 50,000 (4) 2.3 % ― % 8/16/2019 9/1/2019 12/31/2020 $ 5 $ ― FOOTNOTES: (1) The all-in rates are equal to the sum of the Strike and Credit Spread detailed above. (2) Amounts related to interest rate swaps held by the Company which are recorded at fair value and included in either other assets or other liabilities in the accompanying condensed consolidated balance sheets. (3) All or a portion of these derivative financial instruments were settled in connection with the pay down of the respective loan balances. (4) Amounts related to the interest rate caps held by the Company, or its equity method investment, which are recorded at fair value and included in other assets in the accompanying condensed consolidated balance sheets.

Equity (Tables)

Equity (Tables)	9 Months Ended
	Sep. 30, 2019
Equity [Abstract]
Effect of Derivative Financial Instruments	11. Equity (continued) Other comprehensive income (loss) — The following table reflects the effect of derivative financial instruments held by the Company, or its equity method investment, and included in the condensed consolidated statements of comprehensive income (loss) for the quarter and nine months ended September 30, 2019 and 2018 (in thousands): Derivative financial instruments Gain (loss) recognized in other comprehensive loss on derivative financial instruments Location of gain (loss) reclassified into earnings Gain (loss) reclassified from accumulated other comprehensive loss into earnings Quarter Ended Quarter Ended September 30, September 30, 2019 2018 2019 2018 Interest rate swaps $ ― $ (205) Interest expense and loan cost amortization $ ― $ 979 Interest rate caps 32 (40) Interest expense and loan cost amortization (25) (581) Reclassification of interest rate swaps upon derecognition ― 14 Interest expense and loan cost amortization ― (14) Interest rate cap held by unconsolidated joint venture (1) ― Interest expense and loan cost amortization 1 ― Total $ 31 $ (231) $ (24) $ 384 Derivative financial instruments Gain (loss) recognized in other comprehensive loss on derivative financial instruments Location of gain (loss) reclassified into earnings Gain (loss) reclassified from accumulated other comprehensive loss into earnings Nine Months Ended Nine Months Ended September 30, September 30, 2019 2018 2019 2018 Interest rate swaps $ (336) $ 2,102 Interest expense and loan cost amortization $ 813 $ 1,299 Interest rate caps (668) 1,176 Interest expense and loan cost amortization (162) (1,500) Reclassification of interest rate swaps upon derecognition (509) 267 Interest expense and loan cost amortization 509 (267) Reclassification of interest rate caps upon derecognition 265 ― Interest expense and loan cost amortization (265) ― Interest rate cap held by unconsolidated joint venture 11 ― Interest expense and loan cost amortization (11) ― Total $ (1,237) $ 3,545 $ 884 $ (468)

Organization - Additional Infor

Organization - Additional Information (Detail)

Sep. 30, 2015USD ($)

Jul. 31, 2019USD ($)

May 31, 2019Property

Apr. 30, 2019Property

Mar. 31, 2019USD ($)Property

Dec. 31, 2018USD ($)Property

Jul. 31, 2018USD ($)

Apr. 30, 2018Property

Sep. 30, 2019USD ($)State

Sep. 30, 2019USD ($)PropertyStateFacilityHospital

Sep. 30, 2018USD ($)

Dec. 31, 2018Property

Oct. 31, 2015shares

Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]

Entity incorporation, date of incorporation

Jun. 8, 2010

Subscriptions received for common stock through reinvestment plan | $

$ 1,700,000,000

$ 0

$ 0

$ 0

$ 22,013,000

Sale of additional share of common stock | shares

20,000,000

Number of properties

70

Number of properties held for sale

70

70

70

Number of properties sold

59

Number of acute care hospitals | Hospital

3

Healthcare Investment Portfolio

Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]

Number of properties

83

Number of properties held for sale

11

Number of states | State

30

30

Number of seniors housing properties

72

Number of post acute care facilities | Facility

8

Number of acute care hospitals | Hospital

3

MOB Sale Agreement | Welltower Inc.

Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]

MOB sale, gross price | $

$ 1,250,000,000

Number of properties comprised in MOB sale

55

55

IRF Sale Agreement | Global Medical REIT Inc.

Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]

Number of properties held for sale

4

Number of properties sold

4

Gross sales price of properties | $

$ 94,000,000

Beaumont Sale Agreement | Global Medical REIT L.P.

Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]

Gross sales price of properties | $

$ 33,600,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Schedule of Adjusted Consolidated Balance Sheet (Detail) - USD ($) $ in Thousands	Sep. 30, 2019	Jun. 30, 2019	Jan. 01, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Dec. 31, 2017
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Assets held for sale, net	$ 146,719			$ 1,147,645
Total assets	1,656,844			2,705,887
Liabilities associated with assets held for sale	1,076			774,019
Total liabilities	754,668			1,763,961
Accumulated loss	112,961			(233,847)
Total equity	$ 902,176	$ 905,664		$ 941,926	$ 967,861	$ 994,322	$ 1,052,660
Adoption of ASC 842
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Assets held for sale, net			$ 1,148,048
Total assets			2,706,290
Liabilities associated with assets held for sale			771,240
Total liabilities			1,761,182
Accumulated loss			(230,665)
Total equity			945,108
Adoption of ASC 842 | Adjustments
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Assets held for sale, net			403
Total assets			403
Liabilities associated with assets held for sale			(2,779)
Total liabilities			(2,779)
Accumulated loss			3,182
Total equity			$ 3,182

Revenue - Summary of Disaggrega

Revenue - Summary of Disaggregation of Revenue (Detail) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019USD ($)	Sep. 30, 2018USD ($)	Sep. 30, 2019USD ($)Facility	Sep. 30, 2018USD ($)Facility
Disaggregation Of Revenue [Line Items]
Number of Units | Facility			6,080	6,080
Revenues	$ 72,289	$ 69,793	$ 215,452	$ 205,754
Percentage of Revenues			100.00%	100.00%
Independent Living
Disaggregation Of Revenue [Line Items]
Number of Units | Facility			2,261	2,261
Revenues			$ 55,600	$ 53,400
Percentage of Revenues			25.80%	25.90%
Assisted Living
Disaggregation Of Revenue [Line Items]
Number of Units | Facility			2,966	2,966
Revenues			$ 105,000	$ 102,400
Percentage of Revenues			48.70%	49.80%
Memory Care
Disaggregation Of Revenue [Line Items]
Number of Units | Facility			853	853
Revenues			$ 44,600	$ 40,400
Percentage of Revenues			20.70%	19.60%
Other Revenues
Disaggregation Of Revenue [Line Items]
Revenues			$ 10,300	$ 9,600
Percentage of Revenues			4.80%	4.70%

Real Estate Assets, Net - Sched

Real Estate Assets, Net - Schedule of Real Estate Investment Properties Excluding Assets Held For Sale (Detail) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Real Estate [Abstract]
Land and land improvements	$ 130,343	$ 130,133
Building and building improvements	1,476,912	1,475,789
Furniture, fixtures and equipment	84,201	81,666
Less: accumulated depreciation	(269,157)	(232,439)
Real estate investment properties, net	$ 1,422,299	$ 1,455,149

Real Estate Assets, Net - Addit

Real Estate Assets, Net - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Real Estate Investment Properties
Real Estate Properties [Line Items]
Depreciation expense	$ 12.2	$ 12.8	$ 36.7	$ 39.1

Assets and Associated Liabili_3

Assets and Associated Liabilities Held for Sale and Discontinued Operations - Additional Information (Detail) $ in Millions	1 Months Ended				9 Months Ended	12 Months Ended
	May 31, 2019Property	Mar. 31, 2019USD ($)Property	Dec. 31, 2018USD ($)Property	Apr. 30, 2018Property	Sep. 30, 2019PropertyFacilityHospital	Dec. 31, 2018Property
Long Lived Assets Held For Sale [Line Items]
Number of properties committed for sale					70
Number of acute care hospitals | Hospital					3
Number of properties held for sale				70	70	70
Number of other properties					7
Number of properties owned, discontinued operations					63
MOB Sale Agreement | Welltower Inc.
Long Lived Assets Held For Sale [Line Items]
Number of properties comprised in MOB sale	55		55
MOB sale, gross price | $			$ 1,250
Grand Junction Sale Agreement
Long Lived Assets Held For Sale [Line Items]
Date of sale agreement					2019-10
MOB/Healthcare Portfolio
Long Lived Assets Held For Sale [Line Items]
Number of post acute care facilities | Facility					1
MOB/Healthcare Portfolio | IRF Sale Agreement
Long Lived Assets Held For Sale [Line Items]
Number of properties held for sale		4
Gross sales price of properties | $		$ 94
Healthcare Investment Portfolio
Long Lived Assets Held For Sale [Line Items]
Number of post acute care facilities | Facility					8
Number of acute care hospitals | Hospital					3
Number of properties held for sale					11
Welbrook Senior Living Grand Junction
Long Lived Assets Held For Sale [Line Items]
Number of post acute care facilities | Facility					1
Arkansas
Long Lived Assets Held For Sale [Line Items]
Number of skilled nursing facilities | Facility					6
U.S | MOB/Healthcare Portfolio
Long Lived Assets Held For Sale [Line Items]
Number of properties comprised in MOB sale					53
Number of post acute care facilities | Facility					5
Number of acute care hospitals | Hospital					5

Assets and Associated Liabili_4

Assets and Associated Liabilities Held for Sale and Discontinued Operations - Schedule of Assets Classified as Held for Sale and Liabilities Associated with Those Assets Held for Sale (Detail) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Long Lived Assets Held For Sale [Line Items]
Real estate investment properties, net	$ 1,422,299	$ 1,455,149
Deferred rent and lease incentives	15,452	14,763
Other assets	27,772	23,488
Assets held for sale, net	146,719	1,147,645
Liabilities associated with assets held for sale	1,076	774,019
MOB/Healthcare Portfolio
Long Lived Assets Held For Sale [Line Items]
Real estate investment properties, net	76,737
Real estate held for sale, net		952,656
Real estate under development		3,490
Intangibles, net	6,252	82,417
Deferred rent and lease incentives	3,622	36,562
Other assets	1,051	11,425
Restricted cash	86	2,013
Assets held for sale, net	87,748	1,088,563
Mortgages and other notes payable, net		492,701
Credit facilities		212,731
Other liabilities	405	16,653
Accounts payable and accrued liabilities	37	8,425
Liabilities associated with assets held for sale	442	730,510
Other
Long Lived Assets Held For Sale [Line Items]
Real estate investment properties, net	51,339
Real estate held for sale, net		51,339
Intangibles, net	800	800
Deferred rent and lease incentives	6,040	6,501
Other assets	647	182
Restricted cash	145	260
Assets held for sale, net	58,971	59,082
Mortgages and other notes payable, net		8,097
Credit facilities		34,778
Other liabilities	634	634
Liabilities associated with assets held for sale	634	43,509
Disposal Groups Held For Sale
Long Lived Assets Held For Sale [Line Items]
Real estate investment properties, net	128,076
Real estate held for sale, net		1,003,995
Real estate under development		3,490
Intangibles, net	7,052	83,217
Deferred rent and lease incentives	9,662	43,063
Other assets	1,698	11,607
Restricted cash	231	2,273
Assets held for sale, net	146,719	1,147,645
Mortgages and other notes payable, net		500,798
Credit facilities		247,509
Other liabilities	1,039	17,287
Accounts payable and accrued liabilities	37	8,425
Liabilities associated with assets held for sale	$ 1,076	$ 774,019

Assets and Associated Liabili_5

Assets and Associated Liabilities Held for Sale and Discontinued Operations - Summary of Income (Loss) from Discontinued Operations (Detail) - MOB/Healthcare Portfolio - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Revenues:
Rental income and related revenues		$ 4,256	$ 28,458	$ 48,849	$ 85,345
Operating expenses:
Property operating expenses		101	7,800	11,155	22,898
General and administrative		90	295	639	1,057
Financing coordination fees					2,326
Depreciation and amortization			10,592		31,956
Total operating expenses		454	22,425	17,801	70,230
Gain on sale of real estate				331,663
Operating income		3,802	6,033	362,711	15,115
Other income (expense):
Interest and other income (expense)		22	3	33	107
Interest expense and loan cost amortization	[1],[2]		(8,652)	(14,831)	(24,678)
Total other expense		22	(8,649)	(14,798)	(24,571)
Income (loss) before income taxes		3,824	(2,616)	347,913	(9,456)
Income tax expense		53	(18)	(192)	(55)
Income (loss) from discontinued operations		3,877	(2,634)	347,721	(9,511)
Asset Management Fees
Operating expenses:
Asset / Property management fees		254	3,031	4,758	9,094
Property Management Fees
Operating expenses:
Asset / Property management fees		$ 9	$ 707	$ 1,249	$ 2,899
[1]	In connection with the IRF Sale and the MOB Sale, the Company wrote off approximately $3.3 million in unamortized loan costs as a loss on the early extinguishment of debt, which is included in interest expense and loan cost amortization herein for the nine months ended September 30, 2019.
[2]	Interest expense and loan cost amortization directly relates to either: (1) expense on mortgages and other notes payable collateralized by properties classified as discontinued operations; or (2) expense on the Company’s credit facilities that is allocated based on the value of the properties, which are classified as discontinued operations and included in the credit facilities’ unencumbered pool of assets, and the related indebtedness is required to be repaid upon sale of the properties.

Assets and Associated Liabili_6

Assets and Associated Liabilities Held for Sale and Discontinued Operations - Summary of Income (Loss) from Discontinued Operations (Parenthetical) (Detail) - USD ($) $ in Millions	1 Months Ended	9 Months Ended
	Aug. 31, 2019	Sep. 30, 2018
Discontinued Operations And Disposal Groups [Abstract]
Unamortized loan costs written-off	$ 0.1	$ 3.3

Operating Leases - Additional I

Operating Leases - Additional Information (Detail) $ in Millions	1 Months Ended	9 Months Ended	12 Months Ended
	Apr. 30, 2018Property	Sep. 30, 2019USD ($)Property	Dec. 31, 2018Property
Operating Leased Assets [Line Items]
Number of properties held for sale	70	70	70
Lessor, Operating Lease, Existence of Option to Extend [true false]		true
Lessor, operating lease, option to extend		subject to the tenants’ options to extend the lease terms by an additional five years
Triple Net Lease Agreements
Operating Leased Assets [Line Items]
Number of seniors housing properties		15
Number of properties held for sale		11
Total annualized property tax | $		$ 3.2
Weighted average remaining lease term		5 years 3 months 18 days
Extended lease period		5 years
Triple Net Lease Agreements | Minimum
Operating Leased Assets [Line Items]
Lease, expiration year		2022
Triple Net Lease Agreements | Maximum
Operating Leased Assets [Line Items]
Lease, expiration year		2027

Operating Leases - Schedule of

Operating Leases - Schedule of Future Minimum Lease Payments to be Received Under Non-Cancellable Operating Leases Excluding Properties Classified as Discontinued Operations (Detail) $ in Thousands	Sep. 30, 2019USD ($)
Leases [Abstract]
2019	$ 6,906
2020	28,526
2021	29,128
2022	21,541
2023	20,912
Thereafter	50,948
Total	$ 157,961

Variable Interest Entities - Ad

Variable Interest Entities - Additional Information (Detail) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2019USD ($)PropertySubsidiaryConstruction	Dec. 31, 2018Subsidiary
Variable Interest Entity [Line Items]
Maximum exposure to loss VIEs limits | $	$ 25.6
Variable interest entity, description	As of September 30, 2019, the Company had three subsidiaries which are classified as VIEs due to the following factors and circumstances: One of these subsidiaries is an entity with completed real estate under development in which there is insufficient equity at risk due to the development nature of the entity. Two of these subsidiaries are joint ventures with completed real estate under development in which there is insufficient equity at risk due to the development nature of each joint venture.
VIEs
Variable Interest Entity [Line Items]
Number of subsidiaries	3	8
Number of properties being sold in connection with MOB sale | Property	3
Number of construction loans repayment | Construction	2
VIEs | Real Estate Under Development Entities
Variable Interest Entity [Line Items]
Number of subsidiaries	1
VIEs | Joint Ventures Real Estate Under Development Entities
Variable Interest Entity [Line Items]
Number of subsidiaries	2

Variable Interest Entities - Ag

Variable Interest Entities - Aggregate Carrying Amount and Major Classifications of Consolidated Assets and Liabilities (Detail) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Variable Interest Entity [Line Items]
Real estate investment properties, net	$ 1,422,299	$ 1,455,149
Assets held for sale, net	146,719	1,147,645
Cash	37,974	57,109
Other assets	27,772	23,488
Deferred rent and lease incentives	15,452	14,763
Restricted cash	5,309	6,119
Mortgages and other notes payable, net	434,923	530,644
Liabilities associated with assets held for sale	1,076	774,019
Other liabilities	8,997	8,548
VIEs
Variable Interest Entity [Line Items]
Real estate investment properties, net	69,411	146,341
Assets held for sale, net	0	39,601	[1]
Cash	549	342
Other assets	598	678
Deferred rent and lease incentives	0	7,160
Restricted cash	111	208
Mortgages and other notes payable, net	41,816	102,578
Liabilities associated with assets held for sale	0	30,695	[1]
Accounts payable and accrued liabilities	1,139	784
Other liabilities	$ 236	$ 1,321
[1]	Refer to Note 5. “Assets and Associated Liabilities Held For Sale and Discontinued Operations” for additional information.

Indebtedness - Additional Infor

Indebtedness - Additional Information (Detail) $ in Thousands		1 Months Ended			9 Months Ended
		Aug. 31, 2019USD ($)	May 31, 2019USD ($)PropertyExtension	Dec. 31, 2018Property	Sep. 30, 2019USD ($)	Sep. 30, 2018USD ($)
Debt Instrument [Line Items]
Repayments of indebtedness secured by other properties			$ 28,600		$ 600,747	$ 63,712
Unamortized loan costs written-off		$ 100				3,300
Financing coordination fees	[1]				$ 5,351	$ 2,326
Payment for exit fees		400
Maximum allowable distributions as a percentage of adjusted FFO					95.00%
Description of covenants					The credit facilities contain affirmative, negative, and financial covenants which are customary for loans of this type, including (but not limited to): (i) maximum leverage, (ii) minimum fixed charge coverage ratio, (iii) minimum consolidated net worth, (iv) restrictions on payments of cash distributions except if required by REIT requirements, (v) maximum secured indebtedness, (vi) maximum secured recourse debt, (vii) minimum unsecured interest coverage and (viii) limitations on certain types of investments and with respect to the pool of properties supporting borrowings under the credit facilities, minimum weighted average occupancy, and remaining lease terms, as well as property type, MSA, operator, and asset value concentration limits. The limitations on distributions generally include a limitation on the extent of allowable distributions, which are not to exceed the greater of 95% of adjusted FFO (as defined per the credit facilities) and the minimum amount of distributions required to maintain the Company’s REIT status.
Wellmore of Lexington
Debt Instrument [Line Items]
Repayments of outstanding construction loans		$ 21,000
Construction loans scheduled maturity		2019-09
Waterstone on Augusta
Debt Instrument [Line Items]
Repayments of outstanding construction loans		$ 18,700
Construction loans scheduled maturity		2020-09
2014 Revolving Credit Facility
Debt Instrument [Line Items]
Repayments of indebtedness			229,100
First Term Loan Facility
Debt Instrument [Line Items]
Repayments of indebtedness			175,000
Second Term Loan Facility
Debt Instrument [Line Items]
Repayments of indebtedness			275,000
2014 Credit Facility
Debt Instrument [Line Items]
Unamortized loan costs written-off					$ 700
2019 Revolving Credit Facility
Debt Instrument [Line Items]
Aggregate maximum principal amount available for borrowing			$ 250,000
Line of credit facility, initial maturity			2023-05
Number of extension options available | Extension			1
Line of credit facility extension period			12 months
Line of credit facility, initial term			4 years
2019 Term Loan Facility
Debt Instrument [Line Items]
Aggregate maximum principal amount available for borrowing			$ 265,000
Line of credit facility, initial maturity			2024-05
Line of credit facility, initial term			5 years
2019 Credit Facilities
Debt Instrument [Line Items]
Credit facility, interest description					The 2019 Credit Facilities bear interest based on 30-day LIBOR plus a spread that varies with the Company’s leverage ratio.
Welltower Inc. | MOB Sale Agreement
Debt Instrument [Line Items]
Number of properties comprised in MOB sale | Property			55	55
Advisor | 2014 Credit Facility
Debt Instrument [Line Items]
Financing coordination fees			$ 5,200
[1]	For the nine months ended September 30, 2019, the Company incurred financing coordination fees of approximately $5.4 million primarily related to the 2019 Credit Facilities of which approximately $3.5 million were capitalized in the accompanying condensed consolidated balance sheets. For the nine months ended September 30, 2018, the Company incurred financing coordination fees of approximately $2.3 million, which were expensed as incurred. Financing coordination fees associated with the refinancing of debt are either expensed or capitalized based on whether such refinancings are determined to represent loan modifications or loan extinguishments for accounting purposes.

Indebtedness - Details of Indeb

Indebtedness - Details of Indebtedness, Excluding Indebtedness Associated with Assets Held for Sale (Detail) - USD ($) $ in Thousands		Sep. 30, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Premium (discount), net	[1]	$ 153	$ 184
Loan costs, net		(1,329)	(2,429)
Total mortgages and other notes payable, net		434,923	530,644
Credit facilities		282,832	425,613
Total indebtedness, net		717,755	956,257
First Term Loan Facility
Debt Instrument [Line Items]
Credit facilities	[2]		151,616
Second Term Loan Facility
Debt Instrument [Line Items]
Credit facilities	[2],[3]		275,000
2019 Revolving Credit Facility
Debt Instrument [Line Items]
Credit facilities	[3],[4]	20,000
2019 Term Loan Facility
Debt Instrument [Line Items]
Credit facilities	[3]	265,000
Term Loan Facility
Debt Instrument [Line Items]
Loan costs, net		(2,168)	(1,003)
Mortgages payable and other notes payable
Debt Instrument [Line Items]
Mortgages payable and other notes payable	[5]	436,099	532,889
Fixed rate debt
Debt Instrument [Line Items]
Mortgages payable and other notes payable		350,471	358,843
Variable Rate Debt
Debt Instrument [Line Items]
Mortgages payable and other notes payable	[2],[3]	$ 85,628	$ 174,046
[1]	Premium is reflective of the Company recording a mortgage note payable assumed at fair value on the respective acquisition date.
[2]	As of September 30, 2019, the Company did not have any interest rate swaps. As of December 31, 2018, the Company had interest rate swaps with notional amounts of approximately $151.6 million. These interest rate swaps were settled in connection with the refinancing of the credit facilities in May 2019. Refer to Note 10. “Derivative Financial Instruments” for additional information.
[3]	As of September 30, 2019 and December 31, 2018, the Company had interest rate caps with notional amounts of approximately $273.0 million and $330.0 million, respectively. Refer to Note 10. “Derivative Financial Instruments” for additional information.
[4]	As of September 30, 2019 and December 31, 2018, the Company had undrawn availability under the applicable revolving credit facility of approximately $119.4 million and $14.7 million, respectively, based on the value of the properties in the unencumbered pool of assets supporting the loan, which includes certain assets held for sale.
[5]	As of September 30, 2019 and December 31, 2018, the Company’s mortgages and other notes payable are collateralized by 35 and 37 properties, respectively, with total carrying value of approximately $0.7 billion and $0.8 billion, respectively.

Indebtedness - Details of Ind_2

Indebtedness - Details of Indebtedness, Excluding Indebtedness Associated with Assets Held for Sale (Parenthetical) (Detail)	Sep. 30, 2019USD ($)Property	Dec. 31, 2018USD ($)Property
Revolving Credit Facility
Debt Instrument [Line Items]
Debt Instrument, Current borrowing capacity	$ 119,400,000	$ 14,700,000
Secured Mortgages and Other Notes Payable
Debt Instrument [Line Items]
Number of collateralized properties owned | Property	35	37
Mortgages and other notes payable carrying value of collateral	$ 700,000,000	$ 800,000,000
Interest Rate Cap
Debt Instrument [Line Items]
Notional amounts of derivative contract	273,000,000	330,000,000
Interest Rate Swap
Debt Instrument [Line Items]
Notional amounts of derivative contract	$ 0	$ 151,600,000

Indebtedness - Schedule of Matu

Indebtedness - Schedule of Maturities of Indebtedness (Detail) $ in Thousands	Sep. 30, 2019USD ($)
Debt Disclosure [Abstract]
2019	$ 24,344
2020	95,467
2021	11,352
2022	282,216
2023	42,873
Thereafter	265,000
Total borrowings	$ 721,252

Indebtedness - Schedule of Fair

Indebtedness - Schedule of Fair Market Value and Carrying Value of Indebtedness (Detail) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Carrying Value	$ 721,252
Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Fair Value		$ 751,800
Carrying Value		748,300
Mortgages and other notes payable, net
Debt Instrument [Line Items]
Fair Value	440,500	528,700
Carrying Value	434,900	530,600
Credit facilities
Debt Instrument [Line Items]
Fair Value	285,000	426,600
Carrying Value	$ 282,800	$ 425,600

Related Party Arrangements - Ad

Related Party Arrangements - Additional Information (Detail) - USD ($) $ in Thousands	May 10, 2019	Apr. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Related Party Transaction [Line Items]
Cash distributions on restricted stock				$ 20,200	$ 385,985	$ 38,805
Expense Support Agreements | Restricted Stock
Related Party Transaction [Line Items]
Cash distributions on restricted stock			$ 100	$ 200	$ 3,000	$ 500
Advisor
Related Party Transaction [Line Items]
Advisory agreement extended through the date	2020-06
Property Manager
Related Party Transaction [Line Items]
Property management agreement expire stated date		2018-06

Related Party Arrangements - Sc

Related Party Arrangements - Schedule of Fees, Reimbursable Expenses and Related Amounts Unpaid to Related Parties (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018		Dec. 31, 2018
Related Party Transactions [Abstract]
Operating expenses	[1]	$ 1,097	$ 1,444	$ 3,836	$ 4,672
Total reimbursable expenses		1,097	1,444	3,836	4,672
Investment services fees		0		0	60	[2]
Financing coordination fees	[3]			5,351	2,326
Property management fees	[4]				2,323
Asset management fees		4,844	7,593	18,529	22,791
Disposition fees	[5]			2,957	58
Total reimbursable expenses, net		5,941	$ 9,037	30,673	$ 32,230
Operating expenses, unpaid	[1],[6]	557		557			$ 722
Total reimbursable expenses due	[6]	557		557			722
Asset management fees, unpaid	[6]	1,614		1,614			2,533
Total related amount unpaid	[6]	$ 2,171		$ 2,171			$ 3,255
[1]	Amounts are recorded as general and administrative expenses in the accompanying condensed consolidated statements of operations unless such amounts represent prepaid expenses, which are capitalized in the accompanying condensed consolidated balance sheets.
[2]	For the quarter and nine months ended September 30, 2019, the Company did not incur any investment services fees. For the nine months ended September 30, 2018, the Company incurred investment service fees of approximately $0.1 million, which were capitalized and included in real estate assets, net in the accompanying condensed consolidated balance sheets.
[3]	For the nine months ended September 30, 2019, the Company incurred financing coordination fees of approximately $5.4 million primarily related to the 2019 Credit Facilities of which approximately $3.5 million were capitalized in the accompanying condensed consolidated balance sheets. For the nine months ended September 30, 2018, the Company incurred financing coordination fees of approximately $2.3 million, which were expensed as incurred. Financing coordination fees associated with the refinancing of debt are either expensed or capitalized based on whether such refinancings are determined to represent loan modifications or loan extinguishments for accounting purposes.
[4]	No property management fees were payable to the Property Manager subsequent to June 2018 as the property management agreement was not renewed beyond its expiration date in June 2018.
[5]	Amounts are recorded as a reduction to gain on sale of real estate in the accompanying consolidated statements of operations.
[6]	Amounts are recorded as due to related parties in the accompanying condensed consolidated balance sheets.

Related Party Arrangements - _2

Related Party Arrangements - Schedule of Fees, Reimbursable Expenses and Related Amounts Unpaid to Related Parties (Parenthetical) (Detail) - USD ($) $ in Thousands		3 Months Ended	9 Months Ended			15 Months Ended
		Sep. 30, 2019	Sep. 30, 2019	Sep. 30, 2018		Sep. 30, 2019
Related Party Transaction [Line Items]
Investment services fees		$ 0	$ 0	$ 60	[1]
Investment service fees capitalized				100
Financing coordination fees	[2]		5,351	2,326
Loan costs capitalized			$ 3,500
Property management fees	[3]			$ 2,323
Property Manager
Related Party Transaction [Line Items]
Property management fees						$ 0
[1]	For the quarter and nine months ended September 30, 2019, the Company did not incur any investment services fees. For the nine months ended September 30, 2018, the Company incurred investment service fees of approximately $0.1 million, which were capitalized and included in real estate assets, net in the accompanying condensed consolidated balance sheets.
[2]	For the nine months ended September 30, 2019, the Company incurred financing coordination fees of approximately $5.4 million primarily related to the 2019 Credit Facilities of which approximately $3.5 million were capitalized in the accompanying condensed consolidated balance sheets. For the nine months ended September 30, 2018, the Company incurred financing coordination fees of approximately $2.3 million, which were expensed as incurred. Financing coordination fees associated with the refinancing of debt are either expensed or capitalized based on whether such refinancings are determined to represent loan modifications or loan extinguishments for accounting purposes.
[3]	No property management fees were payable to the Property Manager subsequent to June 2018 as the property management agreement was not renewed beyond its expiration date in June 2018.

Derivative Financial Instrume_3

Derivative Financial Instruments - Summary of Derivative Financial Instruments and Corresponding Asset (Liability) (Detail) - USD ($) $ in Thousands		9 Months Ended
		Sep. 30, 2019	Dec. 31, 2018
Derivative Financial Instruments One
Derivative [Line Items]
Strike	[1]	2.30%
Credit Spread	[1]	2.40%
Trade date		Sep. 12, 2014
Forward date		Aug. 1, 2015
Maturity date		Jul. 15, 2019
Fair value asset (liability)			$ 168
Derivative Financial Instruments Two
Derivative [Line Items]
Strike	[1]	1.60%
Credit Spread	[1]	2.00%
Trade date		Dec. 23, 2014
Forward date		Dec. 19, 2014
Maturity date		Feb. 19, 2019
Fair value asset (liability)			220
Derivative Financial Instruments Three
Derivative [Line Items]
Strike	[1]	1.70%
Credit Spread	[1]	2.00%
Trade date		Jan. 9, 2015
Forward date		Dec. 10, 2015
Maturity date		Dec. 22, 2019
Fair value asset (liability)			966
Derivative Financial Instruments Four
Derivative [Line Items]
Strike	[1]	2.30%
Trade date		Aug. 29, 2017
Forward date		Aug. 29, 2017
Maturity date		Sep. 1, 2019
Fair value asset (liability)			247
Derivative Financial Instruments Five
Derivative [Line Items]
Notional amounts of derivative contract	[2],[3]	$ 223,000
Strike	[1]	3.00%
Trade date		Mar. 28, 2018
Forward date		Nov. 30, 2018
Maturity date		Dec. 19, 2019
Fair value asset (liability)			44
Derivative Financial Instruments Six
Derivative [Line Items]
Strike	[1]	3.00%
Trade date		Mar. 28, 2018
Forward date		Jul. 10, 2018
Maturity date		Dec. 19, 2019
Fair value asset (liability)			6
Derivative Financial Instruments Seven
Derivative [Line Items]
Strike	[1]	3.00%
Trade date		Mar. 28, 2018
Forward date		Feb. 19, 2019
Maturity date		Dec. 19, 2019
Fair value asset (liability)			19
Derivative Financial Instruments Eight
Derivative [Line Items]
Strike	[1]	3.00%
Trade date		May 4, 2018
Forward date		May 4, 2018
Maturity date		Dec. 19, 2019
Fair value asset (liability)			$ 6
Derivative Financial Instruments Nine
Derivative [Line Items]
Notional amounts of derivative contract	[3]	$ 10,500
Strike	[1]	3.30%
Trade date		Feb. 28, 2019
Forward date		Mar. 1, 2019
Maturity date		Sep. 1, 2021
Derivative Financial Instruments Ten
Derivative [Line Items]
Notional amounts of derivative contract	[3]	$ 50,000
Strike	[1]	2.30%
Trade date		Aug. 16, 2019
Forward date		Sep. 1, 2019
Maturity date		Dec. 31, 2020
Fair value asset (liability)		$ 5
[1]	The all-in rates are equal to the sum of the Strike and Credit Spread detailed above.
[2]	All or a portion of these derivative financial instruments were settled in connection with the pay down of the respective loan balances.
[3]	Amounts related to the interest rate caps held by the Company, or its equity method investment, which are recorded at fair value and included in other assets in the accompanying condensed consolidated balance sheets.

Equity - Additional Information

Equity - Additional Information (Detail) - USD ($)	Sep. 30, 2015	Jul. 31, 2018	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Class Of Stock [Line Items]
Aggregate proceeds received from offering	$ 1,700,000,000	$ 0	$ 0		$ 0	$ 22,013,000
Cash distribution declared			8,907,000	$ 20,247,000	385,985,000	60,818,000
Cash paid to stockholders				20,200,000	385,985,000	38,805,000
Proceeds from cash distributions reinvestment plan						32,000,000
Return of capital distributed to stockholders			0	0	0	0
Redemptions of common stock			$ 0	4,800,000	$ 0	44,800,000
Common stock approved for redemption value				0		$ 28,300,000
Redemption of common stock, per share						$ 10.14
Suspended redemption request common stock, value				$ 16,400,000		$ 16,400,000
Redemption plan suspended date					Jul. 11, 2018
Description of redemption plan					There can be no guarantee that the Redemption Plan will be reinstated by the Company’s board of directors.
Reinvestment Plan
Class Of Stock [Line Items]
Cash distribution declared		$ 0

Equity - Effect of Derivative F

Equity - Effect of Derivative Financial Instruments (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Derivative Instruments Gain Loss [Line Items]
Derivative instruments, Gain (loss) recognized in other comprehensive loss	$ 31	$ (231)	$ (1,237)	$ 3,545
Interest Expense and Loan Cost Amortization
Derivative Instruments Gain Loss [Line Items]
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	(24)	384	884	(468)
Interest Rate Swap
Derivative Instruments Gain Loss [Line Items]
Derivative instruments, Gain (loss) recognized in other comprehensive loss		(205)	(336)	2,102
Interest Rate Swap | Interest Expense and Loan Cost Amortization
Derivative Instruments Gain Loss [Line Items]
Gain (loss) reclassified from accumulated other comprehensive loss into earnings		979	813	1,299
Interest Rate Cap
Derivative Instruments Gain Loss [Line Items]
Derivative instruments, Gain (loss) recognized in other comprehensive loss	32	(40)	(668)	1,176
Interest Rate Cap | Interest Expense and Loan Cost Amortization
Derivative Instruments Gain Loss [Line Items]
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	(25)	(581)	(162)	(1,500)
Reclassification of Interest Rate Swaps Upon Derecognition
Derivative Instruments Gain Loss [Line Items]
Derivative instruments, Gain (loss) recognized in other comprehensive loss		14	(509)	267
Reclassification of Interest Rate Swaps Upon Derecognition | Interest Expense and Loan Cost Amortization
Derivative Instruments Gain Loss [Line Items]
Gain (loss) reclassified from accumulated other comprehensive loss into earnings		$ (14)	509	$ (267)
Reclassification of Interest Rate Caps upon Derecognition
Derivative Instruments Gain Loss [Line Items]
Derivative instruments, Gain (loss) recognized in other comprehensive loss			265
Reclassification of Interest Rate Caps upon Derecognition | Interest Expense and Loan Cost Amortization
Derivative Instruments Gain Loss [Line Items]
Gain (loss) reclassified from accumulated other comprehensive loss into earnings			(265)
Interest Rate Cap Held by Unconsolidated Joint Venture
Derivative Instruments Gain Loss [Line Items]
Derivative instruments, Gain (loss) recognized in other comprehensive loss	(1)		11
Interest Rate Cap Held by Unconsolidated Joint Venture | Interest Expense and Loan Cost Amortization
Derivative Instruments Gain Loss [Line Items]
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	$ 1		$ (11)

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Income Tax Disclosure [Abstract]
Income tax expense	$ 702	$ 859	$ 1,890	$ 2,404
Current income tax expense	100	200	400	400
Income tax expense, a decrease in deferred tax asset	$ 500	$ 700	$ 1,500	$ 2,000

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) shares in Millions	9 Months Ended
	Sep. 30, 2019USD ($)Agreementshares
Commitments And Contingencies [Line Items]
Number of promoted interest agreements	6
Number of promoted interest agreements not met established performance metrics	5
Number of promoted interest agreements met established performance metrics	1
Company accrued interest to holder's | $	$ 0
Advisor Expense Support Agreement | Restricted Stock
Commitments And Contingencies [Line Items]
Contingently issuable restricted stock shares | shares	1.3

Subsequent Events - Additional

Subsequent Events - Additional Information (Detail) - Subsequent Event $ in Millions	1 Months Ended
	Oct. 31, 2019USD ($)
Beaumont Sale Agreement
Subsequent Event [Line Items]
Net sales price of properties	$ 33.2
Grand Junction Sale Agreement
Subsequent Event [Line Items]
Gross sales price of properties	$ 5.9